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Abstract
In observational studies, treatment may be adapted to covariates at several
times without a fixed protocol, in continuous time. Treatment influences covari-
ates, which influence treatment, which influences covariates, and so on. Then even
time-dependent Cox-models cannot be used to estimate the net treatment effect.
Structural nested models have been applied in this setting. Structural nested models
are based on counterfactuals: the outcome a person would have had had treatment
been withheld after a certain time. Previous work on continuous-time structural
nested models assumes that counterfactuals depend deterministically on observed
data, while conjecturing that this assumption can be relaxed. This article proves
that one can mimic counterfactuals by constructing random variables, solutions to
a differential equation, that have the same distribution as the counterfactuals, even
given past observed data. These “mimicking” variables can be used to estimate the
parameters of structural nested models without assuming the treatment effect to be
deterministic.
Keywords: Causality in continuous time, Dynamic treatments, Longitudinal data, Observa-
tional studies, Panel data, Rank preservation, Stochastic differential equations, Structural
nested models.
1 Introduction
Observational studies are no replacement for randomized clinical trials, but they can be
used, for example, where randomization is unethical or to generate hypotheses for sub-
sequent clinical trials. In an observational study, treatment may be adapted to patient
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characteristics which predict the outcome of interest. This is called confounding by indi-
cation. If the confounding by indication only takes place at baseline, one can condition on
initial person characteristics in order to get meaningful estimates of the treatment effect.
However, if the confounding by indication also takes place after baseline, variables used for
treatment decisions may be influenced by past treatment. Thus they may themselves be
indications of the treatment effect, and in that case simply conditioning on them can lead
to false conclusions.
With such time-dependent confounding by indication, even the time-dependent Cox
model does not estimate the net effect of treatment (see e.g. [21], [24], or [25]). With a
time-dependent Cox model, the rate of events given past treatment and covariate history
can be estimated, but the true parameter(s) on treatment may not reflect the treatment
effect. A consistent estimator of the effect of the treatment on the outcome of interest
has to take into account the effect of treatment on intermediate covariates. This is easily
understood when considering a treatment which affects the outcome only because it affects
an intermediate variable L. In that situation, if L and treatment are both included in the
time-dependent Cox model for the event of interest, the true parameter(s) on treatment in
this Cox model equal 0. However, treatment could be beneficial due to its effect on L. On
the other hand, not including L may also result in an inconsistent estimator, if L predicts
future treatment. This follows from the same reasoning as why, in case of non-randomized
point treatment, one needs to adjust for predictors of both the treatment and the outcome
to consistently estimate the treatment effect: if one does not adjust for L, and if persons
with L indicating a bad prognosis are more likely to be treated, the treatment may seem
to adversely affect the outcome, even if it has no effect on anyone. To conclude, with
time-dependent confounding by indication, one needs to take confounders into account,
but adding the confounders to an outcome model is not enough.
If all confounders are measured (see Assumption 5 below), structural nested models,
proposed in [22, 23, 26], and marginal structural models, proposed in [30, 8], can be used
to consistently estimate treatment effects in the presence of time-dependent confounding
by indication. Structural nested models and marginal structural models make a distinction
between the effect of the treatment and the reason why the treatment was given, by sepa-
rately modeling the treatment decisions and the treatment effect. [27] compares structural
nested models and marginal structural models. The current article focuses on structural
nested models.
Structural nested models model relations between counterfactual outcomes. We allow
for general treatment regimes. Consider a single person, who received a particular treat-
ment regime with outcome Y . For example, the particular treatment regime could be as
follows: first, no treatment, then, after a certain time, initiation of treatment, then, the
dosage changed some time thereafter, then treatment stopped, initiated again, etcetera.
Had the person’s treatment been stopped (prematurely) at time t and not been re-initiated
thereafter (or, had treatment changed to a “baseline” treatment regime from time t on-
wards), the person’s outcome, Y (t), might have been different. Since Y (t) is generally not
observable, it is a counterfactual outcome. In a discrete-time setting, [6] show that exis-
tence of counterfactuals places no restrictions on the distribution of the observed variables.
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No comparable proof exists for the continuous-time case.
An important controversy in the causal literature is that counterfactuals are often
assumed to depend deterministically on the observed data: given the model and the pa-
rameter values, all counterfactual outcomes Y (t) for each person can simply be calculated
from the observed data. [26] calls this local rank preservation (in most cases, this implies
global rank preservation), when the counterfactual outcomes are solutions to the differen-
tial equation (8) in Section 4 below. Treatment is then said not to affect the outcome of
interest if the outcome for any particular person would have been exactly the same regard-
less which treatment was given. The assumption of deterministic dependence is related
to the assumption of constant effect in [9]: that is, the difference between counterfactual
outcomes belonging to different treatments is a constant identical for all persons.
The assumption of deterministic dependence/ (local) rank preservation has frequently
been attacked. This assumption does not hold if, for example, two persons with the same
observed data (e.g., both receiving some prophylactic drug) could have had a different out-
come had they not been treated starting from some time t (e.g., one might have contacted a
virus and the other might not). In addition, deterministic dependence can never be tested,
with only one outcome observed for each person. For these two reasons, the assumption of
(local) rank preservation should be avoided if at all possible.
In discrete time, when treatment and covariates change at fixed times which are the
same for all persons, the theory of structural nested models is well developed. [17] prove
that it is not necessary to assume a deterministic treatment effect. In order to do so, they
show that a certain “blipped down” outcome X(t) mimics the outcome Y (t) had treatment
been withheld from time t onwards, in the sense that X(t) has the same distribution as Y (t)
given past treatment and covariate history. They also indicate why the resulting estimators
for treatment effect are consistent and asymptotically normal.
However, in reality covariates and treatment often change in continuous time. Moreover,
in discrete time the interpretation of the treatment effect (shift- or blip function) depends
on the time scale chosen. In continuous time, the treatment effect (infinitesimal shift
function) can often be interpreted as speed or rate. For these reasons, [23, 28, 18, 11, 10]
have applied continuous-time structural nested distribution models. However, because of
a lack of theory for these models, the applications have relied on the assumption of (local)
rank preservation. The models fitted in [28, 11, 10] are described in Examples 3.1 and 3.2.
Section 5 or, in greater detail, [14] describes how to use the results in the current article
in order to show that assuming (local) rank preservation is not necessary to estimate
treatment effects with structural nested models (an example can be found in Section 9).
Therefore, the main contribution of the current article is showing that the methods in
[23, 28, 18, 11, 10, 26] are robust to failures of the assumption of (local) rank preservation.
Structural nested models in continuous time are meant to estimate the effect of a con-
tinuous treatment, for which the effect of a small duration is small. [26] conjectures that
the appealing large sample properties of discrete-time structural nested models extend to
continuous time; however, his proof requires the assumption of (local) rank preservation.
He conjectures that (i) also without (local) rank preservation, a certain “blipped down”
outcome X(t) has the same distribution as Y (t) given past treatment and covariate history,
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(ii) the resulting estimators are consistent and asymptotically normal, and (iii) for certain
models, estimators and confidence intervals can be calculated with standard software, used
in a non-standard way. This article proves conjecture (i), which we call mimicking coun-
terfactual outcomes, and explains why such a subtle result is true. [14] proves conjecture
(ii), using conjecture (i). [13] proves conjecture (iii), using a partial likelihood approach
and conjectures (i) and (ii). Thus, the current article fills the final link in this methodol-
ogy to estimate treatment effects of time-varying treatments in longitudinal observational
studies without relying on (local) rank preservation. This methodology can be applied to
longitudinal observational data, to study the effects of interventions affecting, for example,
economic and health outcomes.
This article is organized as follows. Section 2 introduces the setting and notation of
this article. Section 3 introduces the model for treatment effect, and shows some examples.
Section 4 defines the mimicking variablesX(t) as the solution to a differential equation with
a final condition. Section 4 also states the main result of this article: X(t) mimics Y (t) in the
sense that it has the same distribution as Y (t), even given past treatment- and covariate
history. Section 5 formalizes the assumption of no unmeasured confounding, which as
shown there is needed to use the result of the current article to estimate the treatment
effect. Section 5 also indicates how, using the mimicking result, tests and estimators can be
developed without assuming (local) rank preservation. Section 6 outlines the proof of the
main result of this article: X(t) mimics Y (t) in the sense that it has the same distribution
as Y (t), even given past treatment- and covariate history. Section 7 proves the main result
of this article for non-survival outcomes Y . Section 8 proves the main result for survival
time outcomes Y . Section 9 describes a simulation study. Section 10 concludes this article
with a discussion.
2 Setting and notation
The setting to which continuous-time structural nested models apply is as follows. The
outcome of interest is a continuous real-valued variable Y . For example, Y is a person’s
survival time, time to clinical AIDS, the number of white blood cells, or the CD4 count.
Our objective is to estimate the effect of treatment on Y . In this article, we consider a
fixed time interval t ∈ [0, τ ] with finite τ , where t = 0 is the time at which follow-up of
interest starts (for example, 0 could be the time of enrollment in a study, or a baseline
time). During the time interval [0, τ ], treatment and person characteristics are observed for
each person. Y is measured at or after time τ , or, in the case of a survival time outcome,
Y could be measured before time τ if the person dies before time τ . We assume that
treatment starts at or after time 0. We suppose that after time τ , treatment is stopped or
switched to some kind of baseline treatment regime. Most of this article assumes that there
is no censoring, and Y is observed for every person in the study. Section 8.4 incorporates
right censoring.
The covariate process describes the course of the disease of a person, e.g. the course of
the blood pressure and the white blood cell count. The covariates which must be included
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are those which both (i) influence a doctor’s treatment decisions and (ii) predict a person’s
prognosis with respect to the outcome of interest. If such covariates are not observed the
assumption of no unmeasured confounding, see Section 5, will not hold.
Denote the probability space by (Ω,F , P ). For the moment consider a single person.
Write Z(t) for the covariate- and treatment values at time t. This article assumes that Z(t)
takes values in Rm, and that Z(t) : Ω → Rm is measurable for each t ∈ [0, τ ]. Moreover,
we assume that Z, seen as a function on [0, τ ], is continuous from the right with limits
from the left (cadlag), and that with probability one this function, or “sample path”, has
only finitely many jumps. We also assume that the probability that the covariate- and
treatment process Z jumps at time t equals 0 for every fixed time t (except possibly for
finitely many fixed times t, which could have point masses). For example, the hazard of the
jumps of the treatment process could be continuous for all t, and could follow a continuous
parametric distribution. Zt = (Z (s) : 0 ≤ s ≤ t) denotes the covariate- and treatment
history until time t, and Z t is the space of cadlag functions from [0, t] to Rm in which Zt
takes its values. Similarly, Z denotes the complete covariate- and treatment history of the
person in the interval [0, τ ], and Z is the space in which Z takes its values. In this article,
the σ-algebra on Z t and Z is the projection σ-algebra; measurability of Z(s) for each s ≤ t
is then equivalent to measurability of the random variable Zt.
Counterfactual outcomes were already mentioned in the introduction. Y (t) is the final
outcome had treatment been stopped (prematurely) at time t and not been re-initiated
thereafter (or changed to some kind of baseline treatment regime 0 from time t onwards).
This article supposes that all counterfactual outcomes Y (t), for t ∈ [0, τ ] and for each
person, are random variables on the probability space (Ω,F , P ). We assume that obser-
vations and counterfactual outcomes of different persons are independent and identically
distributed, and are a random sample from a larger infinite population of interest. For
notational convenience, we suppress the subscript i for person.
3 Model for treatment effect
Structural nested models in continuous time model distributional relations between Y (t)
and Y (t+h), for h > 0 small, through a so-called infinitesimal shift-function D. Write F
for the cumulative distribution function and F−1 : (0, 1) 7→ R for its generalized inverse
F−1 (p) = inf {x : F (x) ≥ p}. Then the infinitesimal shift-function D is defined as
D
(
y, t;Zt
)
=
∂
∂h
∣∣∣∣
h=0
(
F−1
Y (t+h)|Zt
◦ FY (t)|Zt
)
(y) , (1)
the right hand derivative of the quantile-quantile transform which moves quantiles of the
distribution of Y (t) to quantiles of the distribution of Y (t+h) (h ≥ 0), given the covariate-
and treatment history until time t, Zt. In order to define D, no assumptions are necessary
about the joint distribution of the counterfactuals Y (t).
Example 3.1. Survival of AIDS patients. [28] describe an AIDS clinical trial to study the
effect of AZT treatment on survival in HIV-positive patients. Time 0 was the time of en-
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rollment in the study. Embedded within this trial was an uncontrolled observational study
of the effect of prophylaxis therapy for PCP on survival. PCP, Pneumocystis Carinii Pneu-
monia, is an opportunistic infection that affects HIV-positive patients. [28] use continuous-
time structural nested models to study the effect of PCP prophylaxis therapy on survival
of HIV-positive patients. Thus, the outcome of interest, Y , is the survival time, and the
treatment under study is prophylaxis for PCP. Although [28] estimate the effect of changes
in the time the treatment is discontinued, we will consider estimating the effect of changes
in the initiation time of the treatment. This conforms better to the clinical practice in
HIV/AIDS, where PCP prophylaxis is rarely discontinued, and to the assumption in [28]
that once PCP prophylaxis is started, it is never stopped. In this example, Y (t) is the
counterfactual outcome had PCP prophylaxis treatment been as given in reality until time
t and initiated or continued thereafter. We thus define the baseline treatment regime “0”
as “continuously treat with PCP prophylaxis”. In the context of this example, the local
rank preservation assumption of [28] can be expressed as:
Y (t) − t =
∫ Y
t
eψ1no prophylaxis at sds. (2)
Assumption (2) is very strong, because it requires that given the model parameter ψ and the
observed outcome Y , all counterfactual outcomes Y (t) can be calculated from the observed
data. The current article proves that it suffices to assume that
Dψ
(
y, t;Zt
)
=
(
1− eψ) 1{no prophylaxis at t}. (3)
We show that under Assumption (3),
Y (t) − t ∼
∫ Y
t
eψ1no prophylaxis at sds (4)
conditional on Zt and Y > t, where ∼ means “has the same distribution as”. Given Zt,
both Y (t) − t and ∫ Y
t
eψ1no prophylaxis at sds are random variables, depending on Y (t) and Y ,
respectively. Assumption (3) does not impose that Y (t)−t is equal to ∫ Y
t
eψ1no prophylaxis at sds,
but only that the distribution of these two random variables is the same conditional on
Zt and Y > t. Thus, under equation (3), patients who have the exact same observed his-
tory over [0, τ ], Zτ and Y , do not necessarily have the same counterfactual outcomes Y
(t).
This is a substantial relaxation of the assumptions previously adopted in the literature
on continuous-time structural nested models. Relaxing assumption (2) is empirically rele-
vant because in clinical practice Y (t) may differ between two patients with the exact same
observed history. Suppose for example that two patients with the exact same observed
history were both on PCP prophylaxis. If one of the patients got in contact with pneumo-
coccal bacteria (and therefore might have caught PCP without the preventive treatment,
PCP prophylaxis), and the other did not get in contact with pneumococcal bacteria (and
therefore might not have caught PCP, even without PCP prophylaxis), the outcomes for
the two patients without PCP prophylaxis could be different.
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In equation (4), the part of the residual survival time, Y − t, that is untreated gets
multiplied by eψ to attain the same distribution as Y (t)−t (the residual survival time under
“continuous treatment from t onwards”), conditional on Zt and Y > t. Therefore, analo-
gous to accelerated failure time models (see e.g. Cox and Oaks, 1984), the multiplication
factor eψ can be interpreted in a distributional way.
Our results do not depend on adopting the particular specification of the infinitesimal
shift-functionD of equation (3). For example, they also apply to an alternative specification
of D from [28]. In this alternative specification, the effect of the PCP prophylaxis can
depend on the AZT treatment the patient received and whether or not the patient had
a history of PCP prior to the start of PCP prophylaxis. Because the data in [28] were
from a clinical trial for AZT treatment, AZT treatment is described by a single variable R
indicating the treatment arm the patient was randomized to (R equals 1 or 2). Let P (t)
be equal to 1 if the patient had PCP before or at time t and before prophylaxis treatment
started; otherwise P (t) is equal to 0. The model described in [28], but adapted to our
choice of baseline treatment regime (0 is continuous treatment with PCP prophylaxis), is
Dψ1,ψ2,ψ3
(
y, t;Zt
)
=
(
1− eψ1+ψ2P (t)+ψ3R) 1{no prophylaxis at t}. (5)
This article shows that if equation (5) holds, then
Y (t) − t ∼
∫ Y
t
e1{no prophylaxis at s}(ψ1+ψ2P (s)+ψ3R)ds given Zt,
for t < Y .
Example 3.2. Effect of Graft versus Host Disease (GvHD) on time to leukemic relapse.
[10] and [11] use continuous-time structural nested models to study the effect of GvHD
on time to leukemic relapse in patients who had Bone Marrow Transplantation (BMT).
Infection with Cytomegalovirus (CMV) is a time-dependent confounder: an independent
prognostic factor for relapse that both 1. predicts the subsequent development of the
exposure GvHD and 2. is predicted by past exposure GvHD. Write Y for the time until
leukemic relapse. Assume that Y is observed for every patient. In [10] and [11], Y (t) is the
outcome had the patient been exposed (or not) to GvHD as in reality until time t, and not
exposed afterwards. Based on biological knowledge, [10] and [11] assume that
Dψ
(
y, t;Zt
)
=
(
1− eψ) 1{GvHD at t}. (6)
This article shows that then, for t < Y , preventing GvHD from t onwards leads to
Y (t) − t ∼
∫ Y
t
eψ1{GvHD at s}ds given Zt. (7)
[10] and [11] assume that (7) is true even with ∼ replaced by = (although only for t = 0),
hoping that could be relaxed. This article shows that indeed (6) is sufficient to estimate
the effect of GvHD.
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Example 3.3. (Incorporating a-priori biological knowledge, following [26]). Again consider
survival as the outcome of interest. Suppose that it is known that treatment received at
time t only affects survival for patients who would die by time t + 5 if they would receive
no further treatment. An example would be a setting in which failure is death from an
infectious disease, the treatment is a preventive antibiotic treatment which is of no benefit
unless the person is already infected and, if death occurs, it always does within five weeks
from the time of initial unrecorded subclinical infection. In that case, the natural restriction
on D is that
D
(
y, t;Zt
)
= 0 if y − t > 5.
As can be seen from these examples, the parameters of a continuous-time structural
nested model are often rates. More biostatistical examples of models for D can be found
in e.g. [18, 26, 29, 23, 31].
h · D (y, t;Zt) can be interpreted as the infinitesimal effect on the outcome of the
treatment actually given in the time interval [t, t+ h) (relative to the baseline treatment
regime). To be more precise, from the definition of D, it follows that
h ·D (y, t;Zt) = (F−1Y (t+h)|Zt ◦ FY (t)|Zt
)
(y)− y + o (h) .
In Figure 1 (left) this is sketched.
0
1
F−1
Y (t+h)|Zt
◦ FY (t)|Zt(y)y
FY (t+h)|Zt
FY (t)|Zt
p
h ·D (y, t;Zt)+ o(h)
◗
◗
◗s✲✛
X(t)
✲
✻
0 t
y2
y
 
 
 
 
 
 
 
 
 
 
y = t
Y τjump time
of Z
Figure 1: Left: Illustration of the infinitesimal shift-function D.
Right: An example of a solution X(t) to the differential equation dX(t)/dt =
D
(
X(t), t;Zt
)
with final condition X (τ) = Y in case the outcome is survival time.
It can be shown that D ≡ 0 if and only if treatment does not affect the outcome of
interest, as was conjectured in [26]. To be more precise, [12] shows that, for example,
D ≡ 0 if and only if for every h > 0 and t, Y (t+h) has the same distribution as Y (t) given
Zt. That is, D ≡ 0 if and only if “at any time t, whatever person characteristics are
selected at that time (Zt), switching ‘treatment as given’ to ‘baseline treatment regime’ at
some fixed time after t would not change the distribution of the outcome in persons with
these person characteristics”. To prove this one needs the mimicking result of the current
article.
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4 Mimicking counterfactual outcomes
Define X (t) as the continuous solution to the differential equation
dX(t)/dt = D
(
X (t) , t;Zt
)
(8)
with final condition X (τ) = Y , the observed outcome (see Figure 1, right). Then X (t)
mimics Y (t) in the sense that it has the same distribution as Y (t), even given the person’s
treatment- and covariate history at time t, Zt. To prove this main result we need the
following consistency assumption.
Assumption 4.1. (Consistency). Y (τ) has the same distribution as Y given Zτ .
Notice that because no treatment was given after time τ and the treatment process is right
continuous, there is no difference in treatment between Y (τ) and Y . Under this consistency
assumption and regularity conditions only, it is proved in Sections 7 and 8 that indeed (8)
has a unique solution X for every ω ∈ Ω, and that this solution X(t) mimics Y (t) in the
sense that it has the same distribution as Y (t) given Zt.
Example 4.2. Survival of AIDS patients (continuation of Example 3.1). If equation (3)
holds, then
X(t) = t+
∫ Y
t
eψ1{prophylaxis at s}ds
for t < Y , and X(t) = Y for t ≥ Y . Alternatively, if equation (5) holds, then
X(t) = t+
∫ Y
t
e1{prophylaxis at s}(ψ1+ψ2P (s)+ψ3R)ds
for t < Y , and X(t) = Y for t ≥ Y .
5 Estimators, tests, and “no unmeasured confound-
ing”
This section contains a brief summary of [14], who shows how the result of the current
article leads to testing and estimation. In addition, Appendix C provides an example of
estimation in our simulation study.
The main assumption underlying structural nested models is that all information the
doctors used to make treatment decisions, and which is predictive of the person’s prognosis
with respect to the final outcome, is available for analysis. This assumption of no unmea-
sured confounding makes it possible to distinguish between treatment effect and selection
bias; see e.g. [28], [26], [17] or [14].
Assume that the treatment process gives rise to a counting process N(t). For example,
N(t) is the number of treatment changes until time t. The assumption of no unmeasured
confounding is then formalized as
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Assumption 5.1. (No unmeasured confounding). The rate with which N jumps given
Zt− is the same as the rate with which N(t) jumps given Zt− and
(
Y (s) : s < t
)
,
because given the observed Zt−, the (unobserved) prognosis of a person, represented by
Y (s) for s < t, should not predict treatment at or after time t. If it does, there is no way
to distinguish between the effect of the treatment and the reason why it is initiated.
Notice that if X(t) mimics Y (t) in the sense that it has the same distribution as Y (t)
given Zt−, it can be expected that under no unmeasured confounding, the rate with which
N(t) jumps at time t also does not depend on X(t), given Zt−. It can formally be shown
that this is indeed true.
First consider how this leads to testing. If treatment does not affect the outcome of
interest, D ≡ 0 and thus X(t) ≡ Y . So if treatment does not affect the outcome of interest,
changes of treatment at time t should be independent of Y , given Zt−. Thus one can test
whether treatment affects the outcome of interest by testing whether, given Zt−, Y adds
to the prediction model for treatment changes.
Also for estimation of the infinitesimal shift-function D we assume that there is no
unmeasured confounding. Suppose that one has a correctly specified parametric model Dψ
for D. Then one can calculate “Xψ(t)”, the solution to
dXψ (t) /dt = Dψ
(
Xψ (t) , t;Zt
)
(9)
with final condition X(τ) = Y . If X(t) mimics Y (t), then Xψ(t) has the same distribution
as Y (t) given Zt for the true ψ. Since Y
(t) does not add to the prediction model for
treatment changes given Zt−, ψ could then be estimated by picking the ψ for which, given
Zt−, Xψ(t) adds the least to the prediction model for N , treatment changes. This can be
proven to lead to the following theorem:
Theorem 5.2. Suppose that the intensity process λ is bounded, Y () is cadlag, there is no
unmeasured confounding and no instantaneous treatment effect (with probability 1, N() and
Y () do not jump at the same time). Suppose also that for every t ∈ [0, τ ], X(t) has the
same distribution as Y (t) given Zt. Then
E
∫ τ
0
ht
(
X (t) , Zt−
)
(dN(t)− λ (t) dt) = 0
for each ht satisfying a regularity restriction. Thus if Dψ and λθ are correctly specified
parametric models for D and λ, respectively,
Pn
∫ τ
0
ht
(
Xψ (t) , Zt−
)
(dN(t)− λθ (t) dt) = 0,
with Pn the empirical measure PnX = 1/n
∑n
i=1Xi, is an unbiased estimating equation for
(θ0, ψ0), for each ht satisfying a regularity restriction. ht here is allowed to depend on ψ
and θ, as long as it satisfies the regularity restriction for (θ0, ψ0).
In fact, these estimating equations are often martingales at the true parameter. From
e.g. [32], Theorem 5.2 implies that the resulting estimators are, under regularity conditions,
consistent and asymptotically normal.
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6 Outline of the proof
Throughout the proof this article uses fixed versions of FY (t+h)|Zt satisfying all regularity
conditions of Section 7.2. Section 7.3 shows existence of D. It also derives a different
expression for D, which is often used in the rest of the proof. Section 7.4 shows existence
and uniqueness of solutions X(t) to the differential equation with D, equation (8), with
final condition X (τ) = Y .
The proof that this X(t) mimics Y (t) is based on discretization. Section 7.5 therefore
considers the situation where the treatment- and covariate process Z can be fully described
by its values at finitely many fixed times 0 < τ1 < τ2 < . . . < τK and τ . In fact this is the
discrete-time situation studied in [17], but instead of using the shift-function γ described
there as a model this article uses the infinitesimal shift-function D. Proposition 7.9 in
Section 7.5 states that in this discrete-time setting with D instead of γ, X (t) mimics Y (t)
in the sense that it has the same distribution as Y (t) given the discrete-time Zt, under a
regularity condition and Consistency Assumption 4.1. The proof of Proposition 7.9 is rela-
tively easy, because in this discrete-time setting the continuous solution to the differential
equation can be written down explicitly, in terms of conditional distribution functions.
Sections 7.6–7.12 consider the situation where the probability that Z jumps at t equals
zero for all t. We prove that also in this case, X (t) mimics Y (t), under the conditions of
Section 7.2. First, Section 7.6 prepares the discretization by constructing a series Z
(n)
,
containing more and more information on the covariate- and treatment history Z as n
increases. Z
(n)
depends deterministically on Z, so that no extra randomness is necessary
to construct Z
(n)
. The discretization does not change Y (t); just the information on the
treatment- and covariate process considered is reduced. Z
(n)
is a covariate- and treatment
history as considered in Section 7.5. Therefore, D(n) can be defined as
D(n)
(
y, t, Z
(n)
t
)
=
∂
∂h
∣∣∣∣
h=0
(
F−1
Y (t+h)|Z
(n)
t
◦ F
Y (t)|Z
(n)
t
)
(y) (10)
and we define X(n) as the continuous solution to the differential equation
d
dt
X(n)(t) = D(n)
(
X(n)(t), t;Z
(n)
t
)
(11)
with final condition X(n) (τ) = Y . Section 7.7 shows existence of D(n) and provides two
expressions for D(n). Section 7.8 shows that the conditions of the discrete-time result
are satisfied for the discretized situation, so that Proposition 7.9 guarantees that there
exists a continuous solution X(n)(t) to the differential equation (11), with final condition
X(n) (τ) = Y and with the same distribution as Y (t) given Z
(n)
t .
Sections 7.9–7.11 then prove that X(n) (t) converges almost surely to X(t) as n tends
to infinity, using a result from differential equation theory which bounds the difference
between solutions to differential equations. The proof is concluded in Section 7.12, which
shows that X(t) has the same distribution as Y (t) given Zt because X
(n)(t) has the same
distribution as Y (t) given Z
(n)
t and X
(n)(t) converges almost surely to X(t).
11
Section 7.13 indicates how the proof can be adapted to include situations where the
probability that Z jumps at time t is zero except for at finitely many times t.
7 Proof of main result
7.1 Introduction
The purpose of the current article is to prove thatX (t) mimics Y (t). This result is proved in
this section for non-survival outcomes. Section 7.2 states the assumptions and the precise
statement of the result, and Sections 7.3–7.13 provide the proof.
7.2 Mimicking counterfactual non-survival outcomes: assump-
tions and result
This section provides precise conditions under which X(t) mimics Y (t). First, consider the
definition ofD, equation (1). Notice thatD involves an uncountable number of distribution
functions FY (t+h)|Zt . In many cases conditioning on Zt means conditioning on a null-event,
so that these conditional distributions are not unique. Every single conditional distribution
is almost surely unique (see Web-Appendix D), but because an uncountable number of them
is used (t and h are continuous) this is not sufficient for overall almost sure uniqueness.
Therefore the regularity conditions below should be read as: there exists a collection of
conditional distribution functions FY (t+h)|Zt such that all these regularity conditions are
satisfied. These versions of FY (t+h)|Zt are chosen in the definition of D as well as everywhere
else in this article. We only consider h ≥ 0, so the derivative with respect to h at h = 0 is
always the right hand derivative.
With the support of a random variable X this article means those x such that for every
open set Ux containing x, P (X ∈ Ux) > 0. Let y1 and y2 be the lower- and upper limit of
the support of the outcome of interest Y . In this article, these are assumed to be finite,
and moreover it is assumed that
Assumption 7.1. (support).
a) All FY (t+h)|Zt for all t ≥ 0 and for h ≥ 0 have the same bounded support [y1, y2].
b) All FY (t+h)|Zt (y) for all t ≥ 0 and for h ≥ 0 have a continuous non-zero density
fY (t+h)|Zt (y) on y ∈ [y1, y2].
c) There exists an ε > 0 such that fY (t)|Zt (y) ≥ ε for all y ∈ [y1, y2], ω ∈ Ω and t ∈ [0, τ ].
The support condition may be restrictive for certain applications. Nevertheless, most
real-life situations can be approximated this way, since y1 and y2 are can have arbitrary
(finite) values and ε > 0 can be vary small. Although the support condition may well be
stronger than necessary, it simplifies the analysis considerably and, for that reason, it is
adopted here.
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The remaining regularity conditions are smoothness conditions. They allow for non-
smooth-ness where the covariate- and treatment process Z() jumps. This is important since
if the covariate- and treatment process Z() jumps this can lead to a different prognosis for
the person and thus to non-smoothness of the functions concerned.
Assumption 7.2. (continuous derivatives). For ω ∈ Ω fixed,
a) FY (t+h)|Zt (y) is C
1 in (h, y) for y ∈ [y1, y2] and h ≥ 0.
b) If Z does not jump in (t1, t2) then both
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y) and
∂
∂y
FY (t)|Zt (y) are con-
tinuous in (y, t) on [y1, y2]× [t1, t2) and can be continuously extended to [y1, y2]× [t1, t2].
Structural nested models in continuous time are meant to estimate the effect of a con-
tinuous treatment, for which the effect of a small duration is small. Then, Assumption 7.3
is a regularity condition:
Assumption 7.3. (bounded derivatives).
a) There exists a constant C1 such that for all ω ∈ Ω, t, h ≥ 0 and y ∈ [y1, y2],
∂
∂y
FY (t+h)|Zt (y) ≤ C1.
b) There exists a constant C2 such that for all ω ∈ Ω, t, h ≥ 0 and y ∈ [y1, y2],∣∣∣ ∂
∂h
FY (t+h)|Zt (y)
∣∣∣ ≤ C2.
Assumption 7.4. (Lipschitz continuity).
a) There exists a constant L1 such that for all ω ∈ Ω and t and y, z ∈ [y1, y2],∣∣∣ ∂
∂y
FY (t)|Zt (y)−
∂
∂z
FY (t)|Zt (z)
∣∣∣ ≤ L1 |y − z| .
b) There exists a constant L2 such that for all ω ∈ Ω and t and y, z ∈ [y1, y2],∣∣∣∣ ∂∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)−
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (z)
∣∣∣∣ ≤ L2 |y − z| .
The main theorem of this article is
Theorem 7.5. (mimicking counterfactual outcomes). Suppose that Regularity Conditions
7.1–7.4 are satisfied. Then D
(
y, t;Zt
)
exists. Furthermore for every ω ∈ Ω there exists
exactly one continuous solution X(t) to dX(t)/dt = D
(
X(t), t;Zt
)
with final condition
X (τ) = Y . If also Consistency Assumption 4.1 is satisfied, then this X(t) has the same
distribution as Y (t) given Zt for all t ∈ [0, τ ].
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7.2.1 Simpler regularity conditions
I state some more restrictive but simpler conditions implying all the conditions in Sec-
tion 7.2:
Assumption 7.6. (regularity condition).
• (support).
a) There exist finite numbers y1 and y2 such that all FY (t+h)|Zt have the same
bounded support [y1, y2].
b) All FY (t+h)|Zt (y) have a continuous non-zero density fY (t+h)|Zt (y) on y ∈ [y1, y2].
c) There exists an ε > 0 such that fY (t)|Zt (y) ≥ ε for all y ∈ [y1, y2], ω ∈ Ω and
t ∈ [0, τ ].
• (smoothness). For every ω ∈ Ω
a) (y, t, h)→ FY (t+h)|Zt (y) is differentiable with respect to t, y and h with continu-
ous derivatives on [y1, y2] × [t1, t2) × [0,∞) if Z does not jump in (t1, t2), with
a continuous extension to [y1, y2]× [t1, t2]× [0,∞).
b) The derivatives of FY (t+h)|Zt (y) with respect to y and h are bounded by constants
C1 and C2, respectively.
c) ∂
∂y
FY (t)|Zt(y) and
∂
∂h
∣∣
h=0
FY (t+h)|Zt(y) have derivatives with respect to y which
are bounded by constants L1 and L2, respectively.
7.3 Existence of and a different expression for D
The lemma below can be used to prove existence of D and to find a useful formula for D
(and later two useful formulas for D(n) in Section 7.5):
Lemma 7.7. Suppose that Fh is a family of non-decreasing functions. Suppose that there
exists a neighbourhood U0,y0 of (0, y0) so that Fh (y) is differentiable with respect to y and
h on U0,y0 ∩ {h ≥ 0}. For h = 0, the right hand derivative is meant. Suppose furthermore
that these derivatives are continuous in (h, y). If also F ′0 (y0) is non-zero then there exists
a neighbourhood V0,y0 of (0, y0) such that on the restriction of this neighbourhood to h ≥ 0,
Fh is invertible. Moreover,
(
∂
∂h
F−1h
)
(Fh (y)) exists and satisfies
∂
∂h
Fh (y) + F
′
h (y) ·
(
∂
∂h
F−1h
)
(Fh (y)) = 0.
Proof. Define an extension of F to
U˜0,y0 = {(y, h) : h ≥ 0 and (y, h) ∈ U0,y0} ∪ {(y, h) : h < 0 and (y,−h) ∈ U0,y0} ,
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an open neighbourhood of (0, y0), in the following way:
F˜h (y) =
{
Fh (y) if h ≥ 0
2F0 (y)− F−h (y) if h < 0.
Define φ : Uh0,y0 → R2 as φ (h, y) =
(
h, F˜h (y)
)
. The result follows from the Local Inverse
Function Theorem and direct calculation, after noticing that D
(
φ ◦ φ−1) is the identity
mapping; see Web-Appendix E for details. ✷
Because of Assumptions 7.2a and 7.1c, Lemma 7.7 can be applied to Fh (y) = FY (t+h)|Zt (y)
with y0 = y. Thus D as defined in equation (1) exists and
D
(
y, t;Zt
)
= −
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∂
∂y
FY (t)|Zt (y)
. (12)
7.4 Existence and uniqueness of X(t)
This section shows that the differential equation dX(t)/dt = D
(
X(t), t;Zt
)
with final
condition X (τ) = Y has a unique continuous solution. Fix ω for the rest of Section 7.4.
Since D may be discontinuous at the jump times of the covariate- and treatment process
Z, we consider the intervals between jumps of Z separately. It suffices to prove existence
and uniqueness of X(t) with final condition on any interval between jumps of Z, because
with probability one Z only jumps finitely many times.
Hence suppose that Z does not jump in (t1, t2) and that t1 is either a jump time of
Z or 0 and that t2 is either a jump time of Z or τ . From equation (12) I conclude that
D
(
y, t;Zt
)
is continuous on [y1, y2] × [t1, t2) because of Assumptions 7.2b and 7.1c. The
differential equation has a final condition at the upper end of the interval [t1, t2). Therefore
we define D˜ on [y1, y2]× [t1, t2] as
D˜ (y, t) =
{
D
(
y, t;Zt
)
if t ∈ [t1, t2)
limt↑t2 D
(
y, t;Zt
)
if t = t2.
This limit exists because of Assumption 7.1c and the extension-assumption in Assump-
tion 7.2b. It makes D˜ continuous on [y1, y2] × [t1, t2]. When calculating the continuous
solution to dX(t)/dt = D
(
X(t), t;Zt
)
on [t1, t2], one means to use D˜ on [t1, t2] if D jumps
at t2.
To prove existence and uniqueness of X on [t1, t2], we apply Theorem A.1 to the dif-
ferential equation with D˜. We check the conditions of Theorem A.1 for D˜. Continuity of
D˜ was shown in the previous paragraph. F−1
Y (t+h)|Zt
◦ FY (t)|Zt (y1) = y1 for all h because of
Assumption 7.1a and b, so that D
(
y1, t;Zt
)
= 0. Similarly, D
(
y2, t;Zt
)
= 0. To show that
equation (25) holds, notice that global Lipschitz continuity of D˜ in y on [y1, y2] × [t1, t2)
with Lipschitz constant C = L2/ε+L1C2/ε
2 follows from equation (12), since the numera-
tor is bounded by C2 and is Lipschitz with Lipschiz constant L2 and also the denominator
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is Lipschitz with Lipschitz constant L1 and bounded away from 0 by ε (Assumptions 7.4,
7.3b and 7.1c; see Web-Appendix F). This same constant works on [y1, y2] × [t1, t2] by
continuity. By Theorem A.1, the differential equation (8) with D˜ has a unique solution,
and this solution stays in [y1, y2].
7.5 Mimicking counterfactual outcomes: discrete time
This section considers the situation where Z, the available information on the treatment-
and covariate process, can be fully described by its values at finitely many fixed time points
0 = τ0 < τ1 < τ2 < . . . < τK < τK+1 = τ . At these time points, Z(t) may jump with
probability greater than zero. We prove that in this situation, X(t) mimics Y (t).
We assume that there exist conditional distribution functions ([2], [20]) FY (t)|Zτk
satis-
fying the following regularity condition:
Assumption 7.8. (smoothness). Suppose that for k = 0, . . . , K and t ∈ [τk, τk+1] there
exist conditional distribution functions FY (t)|Zτk
such that
a) For all t ∈ [τk, τk+1], FY (t)|Zτk (y) is continuous in y.
b) For all t ∈ [τk, τk+1], the support of FY (t)|Zτk (y) is an interval.
c) For x ∈ [0, 1] fixed, F−1
Y (t)|Zτk
(x) is differentiable with respect to t on [τk, τk+1].
Throughout Section 7.5, fixed versions of FY (t)|Zτk
(y) are used satisfying Assump-
tion 7.8. Since Zt contains the same information as Zτk for t ∈ [τk, τk+1), we can and
will choose the same versions when conditioning on Zt.
Proposition 7.9. (mimicking counterfactual outcomes in discrete time). Suppose that
the treatment- and covariate process Z can be fully described by its values at finitely many
fixed points 0 = τ0 < τ1 < τ2 < . . . < τK < τK+1 = τ , and suppose also that Smoothness
Assumption 7.8 is satisfied. Then D
(
y, t;Zt
)
as defined in equation (1) exists for all t.
Furthermore if also Assumption 4.1 (consistency) is satisfied, then there exists a continuous
solution X(t) to dX(t)/dt = D
(
X(t), t;Zt
)
with final condition X (τ) = Y for which X (t)
has the same distribution as Y (t) given Zt.
Proof. For t ∈ [τk, τk+1), D
(
y, t;Zt
)
= ∂
∂h
∣∣
h=0
(
F−1
Y (t+h)|Zτk
◦ FY (t)|Zτk
)
(y), so existence of
D
(
y, t;Zt
)
on each interval [τk, τk+1) follows from Assumption 7.8c.
Next, define X˜ as follows. X˜ (τ) = Y , and for t ∈ [τk, τk+1) (k = 0, . . . , K − 1),
X˜(t) = F−1
Y (t)|Zτk
◦ F
Y (τk+1)|Zτk
◦ . . . ◦ F−1
Y (τK−1)|ZτK−1
◦ F
Y (τK)|ZτK−1
◦
◦F−1
Y (τK)|ZτK
◦ FY (τ)|ZτK (Y ) .
16
X˜(t) is well-defined because of Assumption 7.8a and b. First we show that X˜ = X : it is a
continuous solution to X˜ ′(t) = D
(
X˜(t), t;Zt
)
with X˜ (τ) = Y . Next we show that X˜ (t)
has the same distribution as Y (t) given Zt.
Continuity of X˜ on [τk, τk+1) is clear from Assumption 7.8c. Moreover,
lim
t↑τk+1
X˜ (t) = lim
t↑τk+1
F−1
Y (t)|Zτk
◦ F
Y (τk+1)|Zτk
(
X˜ (τk+1)
)
= F−1
Y (τk+1)|Zτk
◦ F
Y (τk+1)|Zτk
(
X˜ (τk+1)
)
because of Assumption 7.8c, which is equal to X˜ (τk+1) because of Assumption 7.8b. Thus,
X˜(t) is also continuous from the left at t = τk+1. For t ∈ [τk, τk+1), X˜ satisfies the
differential equation:
X˜ ′ (t) =
∂
∂h
∣∣∣∣
h=0
F−1
Y (t+h)|Zτk
◦ F
Y (τk+1)|Zτk
(
X˜ (τk+1)
)
=
(
∂
∂h
∣∣∣∣
h=0
F−1
Y (t+h)|Zt
◦ FY (t)|Zt
)
◦ F−1
Y (t)|Zτk
◦ F
Y (τk+1)|Zτk
(
X˜ (τk+1)
)
= D
(
X˜(t), t;Zt
)
,
where in the second line it is used that conditioning on Zt is the same as conditioning on
Zτk , so that FY (t)|Zt ◦ F−1Y (t)|Zτk is the identity because of Assumption 7.8a and b. Thus
indeed X˜ is a continuous solution to X˜ ′(t) = D
(
X˜(t), t;Zt
)
with X˜ (τ) = Y .
Next, we prove that X˜(t) has the same distribution as Y (t) given Zt by induction,
starting at t = τ , then t ∈ [τK , τ), etcetera. For t = τ , X˜ (τ) = Y , so that X˜(τ) has the
same distribution as Y (τ) given Zτ because of Assumption 4.1. For the induction step,
suppose that for t ∈ [τk, τ ] (for k = K + 1 read t = τ), X˜(t) has the same distribution as
Y (t) given Zt. Thus, X˜ (τk) has the same distribution as Y
(τk) given Zτk , and hence X˜ (τk)
also has the same distribution as Y (τk) given Zτk−1 . Therefore Assumption 7.8a implies
that F
Y (τk)|Zτk−1
(
X˜ (τk)
)
is uniformly distributed on [0, 1] given Zτk−1 (Lemma D.8 has
a formal proof). Then X˜(t) = F−1
Y (t)|Zτk−1
◦ F
Y (τk)|Zτk−1
(
X˜ (τk)
)
has distribution function
FY (t)|Zτk−1
given Zτk−1 (Lemma D.9 has a formal proof), so also given Zt. That finishes
the induction step, so that indeed X˜(t) mimics Y (t) for all t ∈ [0, τ ]. ✷
7.6 Discretization and choices of conditional distributions
We return to the continuous-time setting and define a discretization of the covariate-
and treatment process Z. Later, we will apply the result of the previous section to this
discretized continuous-time setting. This section also chooses versions of the conditional
distribution functions given this discretized process.
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For n fixed define τ
(n)
0 = 0, τ
(n)
1 =
1
2n
τ , τ
(n)
2 =
2
2n
τ , ..., τ
(n)
2n =
2n
2n
τ = τ . Consider the
grid at stage n consisting of these points. This way the interval [0, τ ] is split up into 2n
intervals of equal length, and when n increases points are added in the middle of these
intervals. For ease of notation, the superscript (n) in τ
(n)
k is dropped if it is clear which n
is meant. Define Z
(n)
t =
(
Z
(
τ
(n)
k
)
: 0 ≤ τ (n)k ≤ t
)
if Z takes values in a discrete space,
Z
(n)
t =
(
1[ i2n ,
i+1
2n )
(
Z
(
τ
(n)
k
))
: 0 ≤ τ (n)k ≤ t, i ∈ Z
)
if Z takes values in R and
Z
(n)
t =
(
1[ i2n ,
i+1
2n )
(
Z
(
τ
(n)
k
)
j
)
: 0 ≤ τ (n)k ≤ t, i ∈ Z, j = 1, . . . , m
)
if Z takes values in Rm.
With this discretization, the information about Zt contained in Z
(n)
t increases with n: once
a grid point is added it stays on the grid for n larger, and the information about Z in a
fixed grid point also increases with n. Note also that Z
(n)
t depends deterministically on Zt,
so that no extra randomness is necessary to construct Z
(n)
t . Thus Z
(n)
t has the properties
promised in the outline of the proof, Section 6.
Next, versions of conditional distributions are chosen. Recall Zτk takes values in the
space of cadlag functions on [0, τk] with the projection σ-algebra, which is the same as
the Skorohod-σ-algebra ([3] Theorem 14.5). This space is Polish ([3] Chapter 3). There-
fore, there exists a conditional distribution P
Zτk |Z
(n)
τk
([2] Section 10.3 or [20]). Moreover,
P
(
Y (t+h) ≤ y∣∣Z(n)τk ) = ∫ FY (t+h)|Zτk=z (y)dPZτk |Z(n)τk (z) a.s.. This is a conditional distribu-
tion function: it is non-decreasing in y since all FY (t+h)|Zτk=z
(y) are non-decreasing because
they are conditional distribution functions, and because of Lebesgue’s Dominated Conver-
gence Theorem the limit for y → −∞ equals 0 and the limit for y →∞ equals 1. Therefore,
the following choices can be made:
Notation 7.10. We choose fixed conditional distributions P
Zτk |Z
(n)
τk
. I also choose
F
Y (t)|Z
(n)
τk
(y) =
∫
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z) ,
with FY (t)|Zτk=z
as in Section 7.2, to be the version of the conditional distribution function
of Y (t) given Z
(n)
τk
which is used in the rest of the proof. If s ∈ (τk, τk+1), the same version
for F
Y (t)|Z
(n)
s
is chosen; this is possible since for s ∈ (τk, τk+1), Z(n)s = Z(n)τk .
Notice that Z(n) has been constructed with values in a discrete space. This will assure
that the two different expressions for D(n) in Section 7.7 below are equal except for at a
null set which does not depend on y and t.
7.7 Existence of and two expressions for D(n)
This section proves existence of D(n) as defined in equation (10), Section 6. Moreover, two
useful formulas for D(n) are proven. One is used to prove smoothness of D(n), the other
formula is used to prove that D(n) converges to D.
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First, existence of D(n) is shown. Fix n and t, and choose τ
(n)
k such that t ∈
[
τ
(n)
k , τ
(n)
k+1
)
.
Define
Fh(y) = FY (t+h)|Z(n)τk
(y) =
∫
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z) .
To apply Lemma 7.7 on Fh (y), in (h0, y0) = (0, y), we check the conditions. Clearly, Fh(y)
is non-decreasing. We show that Fh (y) is differentiable with respect to y with derivative∫
∂
∂y
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z). For ω fixed, P
Zτk |Z
(n)
τk
is a probability measure on Zτk .
Moreover, ∂
∂y
FY (t+h)|Zτk=z
(y) is bounded by C1, which is integrable with respect to PZτk |Z
(n)
τk
,
and also FY (t+h)|Zτk=z
(y) is integrable with respect to P
Zτk |Z
(n)
τk
, since bounded by 1. There-
fore, Fh (y) is differentiable with respect to y with derivative
∫
∂
∂y
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z).
With the same reasoning (but with Assumption 7.3b instead of 7.3a), Fh (y) is differentiable
with respect to h with derivative
∫
∂
∂h
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z). That these derivatives
of Fh(y) with respect to y and h are continuous in (y, h) follows from Lebesgue’s Dominated
Convergence Theorem applied on the expressions we just derived (the conditions are satis-
fied because of Assumptions 7.2a and 7.3). Furthermore, F ′0 (y) =
∫
∂
∂y
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)
is non-zero (Assumption 7.1b). Thus the conditions of Lemma 7.7 are satisfied for Fh(y),
and therefore ∂
∂h
F−1
Y (t+h)|Z
(n)
τk
(y) exists, and D(n)
(
y, t;Z
(n)
t
)
exists and satisfies
D(n)
(
y, t;Z
(n)
t
)
=
∂
∂h
∣∣∣∣
h=0
(
F−1
Y (t+h)|Z
(n)
τk
◦ F
Y (t)|Z
(n)
τk
)
(y)
= −
∂
∂h
∣∣
h=0
∫
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)
∂
∂y
∫
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)
= −
∫
∂
∂h
∣∣
h=0
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)∫
∂
∂y
FY (t)|Zτk=z
(y)dP
Zτk |Z
(n)
τk
(z)
. (13)
Next, the second expression for D(n) is derived. We show that there exists an Ω′ ⊂ Ω
with probability one such that
D(n)
(
y, t;Z
(n)
t
)
= −
E
[
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∣∣Z(n)t ]
E
[
∂
∂y
FY (t)|Zt (y)
∣∣Z(n)t ] ∀ω ∈ Ω
′ ∀y ∀t ∀n. (14)
First we choose this Ω′, in such a way that on Ω′ conditional probabilities given Z
(n)
τk
are
unique, for all n and τk. Fix n and τk for a moment. It is known from general theory about
conditioning that conditional probabilities given Z
(n)
τk
= z can be written as a measurable
function of z. It is also known that conditional probabilities given Z
(n)
τk
= z are almost
surely unique. Combining these two facts, it follows that conditional probabilities given
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Z
(n)
τk
= z are unique except for at ω’s for which Z
(n)
τk
(ω) has probability zero, that is, except
for ω’s in ⋃
z:P (Z
(n)
τk
=z)=0
{
ω ∈ Ω : Z(n)τk (ω) = z
}
.
Since, by construction, Z
(n)
τk
takes only countably many values, this is a countable union of
null sets and thus a null set. Define
Ω′ = Ω \
⋃
n∈N
⋃
k∈{0,...,2n}
⋃
z:P (Z
(n)
τk
=z)=0
{
ω ∈ Ω : Z(n)τk (ω) = z
}
. (15)
This set has probability one since its complement is a countable union of null sets: N is
countable and for each n there are only finitely many k. On this Ω′ conditional probabilities
given Z
(n)
τk
are unique, for all n and τk.
Next, it is shown that equation (14) holds for Ω′ as defined in equation (15). As shown
in Section 7.6, there exists a conditional distribution P
Zt|Z
(n)
τk
. For t ≥ τk and h ≥ 0,
Fh(y) := P
(
Y (t+h) ≤ y|Z(n)τk
)
=
∫
FY (t+h)|Zt=z (y) dPZt|Z(n)τk
(z) a.s.. On Ω′ this version
is the same as the one used in the definition of D(n) of equation (10), since conditional
probabilities given Z
(n)
τk
are unique on Ω′. Verifying the conditions of Lemma 7.7 can be
done in exactly the same way as for the first expression for D(n). Therefore, Lemma 7.7
implies that for ω ∈ Ω′ and t ∈ [τk, τk+1),
D(n)
(
y, t;Z
(n)
t
)
=
∂
∂h
∣∣∣∣
h=0
(
F−1
Y (t+h)|Z
(n)
τk
◦ F
Y (t)|Z
(n)
τk
)
(y)
= −
∂
∂h
∣∣
h=0
∫
FY (t+h)|Zt=z (y) dPZt|Z(n)τk
(z)
∂
∂y
∫
FY (t)|Zt=z (y) dPZt|Z(n)τk
(z)
= −
E
[
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∣∣Z(n)τk ]
E
[
∂
∂y
FY (t)|Zt (y)
∣∣Z(n)τk ] .
Equation (14) follows.
7.8 Applying the discrete-time result
Lemma 7.11. Suppose that Regularity Conditions 7.1–7.4 and Consistency Assumption 4.1
are satisfied. Then for every n there exists a continuous solution X(n)(t) to the differen-
tial equation with D(n) with final condition X(n) (τ) = Y . X(n) (t) is unique on Ω′ of
equation (15). Furthermore, X(n) (t) has the same conditional distribution as Y (t) given
Z
(n)
t .
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Proof. Fix n. First, we show that there exists a continuous solution X(n) for which
X(n) (t) has the same conditional distribution as Y (t) given Z
(n)
t , using Proposition 7.9.
Thus we check that the conditional distributions F
Y (t)|Z
(n)
τk
of Y (t) given Z
(n)
τk
chosen in
Notation 7.10 satisfy Assumption 7.8. In the second paragraph of Section 7.7, we showed
that F
Y (t)|Z
(n)
τk
(y) is strictly increasing and differentiable with respect to y on [y1, y2], which
accounts for Assumption 7.8a and b. Just before equation (13), it was concluded that
for x ∈ [0, 1] fixed, F−1
Y (t)|Z
(n)
τk
(x) is differentiable with respect to t on [τk, τk+1], which
accounts for Assumption 7.8c. Hence Proposition 7.9 guarantees existence of a continuous
solution X(n) to X(n)(t)′ = D(n)
(
X(n)(t), t
)
with final condition X(n)(τ) = Y and with
X(n)(t) ∼ Y (t) given Z(n)t .
Proposition 7.9 does not imply that X(n) is unique. Almost sure uniqueness of X(n)
follows with Theorem A.1 in the Appendix along the same lines as uniqueness of X (see
Section 7.4), but using equations (13) and (14) for D(n) instead of equation (12) for D, as
follows. Fix n and suppose that t ∈ [τk, τk+1). First, it is proven that D(n) is continuous on
[y1, y2]× [τk, τk+1) with a continuous extension to [y1, y2]× [τk, τk+1], using equation (13).
Expression (13) forD(n) has an obvious extension D˜(n) to [τk, τk+1]. We prove that this D˜
(n)
is continuous on [y1, y2]×[τk, τk+1]. To show that
∫
∂
∂h
∣∣
h=0
FY (t+h)|Zτk=z
(y)dP
Zτk |Z
(n)
τk
(z) and∫
∂
∂y
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z) are continuous in (y, t) Lebesgue’s Dominated Convergence
Theorem can be used, as follows.
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zτk=z
(y) =
∂
∂h
∣∣∣∣
h=t−τk
FY (τk+h)|Zτk=z
(y)
and
∂
∂y
FY (t)|Zτk=z
(y) =
∂
∂y
F
Y (τk+(t−τk))|Zτk=z
(y)
are continuous in (y, t) because of Assumption 7.2a. Both these derivatives are bounded
because of Assumption 7.3. Therefore Lebesgue’s Dominated Convergence Theorem im-
plies that the integrals of these derivatives with respect to the measure µ = P
Zτk |Z
(n)
τk
are
continuous in (y, t). Because of Assumption 7.1b the denominator of D˜(n) is non-zero for
y ∈ [y1, y2], so that indeed D˜(n) is continuous in (y, t) on [y1, y2]× [τk, τk+1].
Next, it is shown that D(n) is Lipschitz continuous in y on [y1, y2]× [τk, τk+1] with Lips-
chitz constant L2/ε+C2L1/ε
2 for all ω ∈ Ω′, with Ω′ as in equation (15). Expression (13)
for D(n) on Ω′ has an obvious extension D˜(n) to [τk, τk+1]. That this D˜
(n) is Lipschitz con-
tinuous in y on [y1, y2]× [τk, τk+1] with Lipschitz constant L2/ε+C2L1/ε2 on Ω′ follows the
same way as forD in Section 7.4. Because of Assumption 7.1c, the denominator is bounded
away from 0 for y ∈ [y1, y2], and because of Assumption 7.1a, the numerator is equal to
zero for y = y1 and for y = y2. Hence, on Ω
′, D˜(n)(y1, t) = D˜
(n)(y2, t) = 0. Therefore
Theorem A.1 implies that, on Ω′, there exists a unique solution to the differential equation
with D˜(n) on [τk, τk+1], and this solution stays in [y1, y2]. Since for n fixed there are only
finitely many τk, the same is true on [0, τ ]. ✷
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7.9 Bounding the difference between X and X(n) in terms of D
and D(n)
To bound the difference between X and X(n) in terms of D and D(n), Theorem A.1 is
applied on y = X (t) and z = X(n) (t). Since we need that both D and D(n) are continuous,
we apply Theorem A.1 on the intervals between the jumps of Z and the grid points τ
(n)
k .
Fix n and restrict ω to ω ∈ Ω′, with Ω′ the set of probability one as defined in equation (15),
so that the expression for D(n) of equation (14) can be used. The bound will thus hold
almost surely. To focus attention on the differential equations, the Zt’s and Z
(n)
t ’s in D
and D(n) are skipped below.
Suppose that (t1, t2) is such an interval including no jumps of Z and no grid points
at stage n. We check the conditions of Theorem A.1 for y = X (t) and z = X(n) (t).
Section 7.4 already showed that D : [y1, y2] × [t1, t2) → R has a continuous extension
D˜ : [y1, y2]×[t1, t2]→ R which satisfies the conditions of Theorem A.1, with C the constant
function L2/ε+C2L1/ε
2, and in the proof of Lemma 7.11 in Section 7.8, it was shown that
on Ω′ the same is true for D(n). Therefore Theorem A.1 implies that for t ∈ [t1, t2], with
C = L2/ε+ C2L1/ε
2 as above,
∣∣X(n)(t)−X(t)∣∣ ≤ e∫ t2t C ds ∣∣X(n) (t2)−X (t2)∣∣
+
∫ t2
t
e
∫ s
t
C dη
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ ds
= eC·(t2−t)
∣∣X(n) (t2)−X (t2)∣∣
+
∫ t2
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ ds. (16)
If Z does not jump in [(1− 1/2n) τ, τ ], (16) can be applied on [(1− 1/2n) τ, τ ], and
since X(n) (τ) = X (τ) = Y it follows that on [(1− 1/2n) τ, τ ],
∣∣X(n)(t)−X(t)∣∣ ≤ ∫ τ
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ ds. (17)
If Z does not jump after (1− 2/2n) τ one can also apply (16) on [(1− 2/2n) τ, (1− 1/2n) τ ],
and using equation (17) for t = (1− 1/2n) τ , it follows that equation (17) also holds on
[(1− 2/2n) τ, (1− 1/2n) τ ]:∣∣X(n)(t)−X(t)∣∣
≤ eC·((1− 12n )τ−t)
∫ τ
(1− 12n )τ
eC·(s−(1−
1
2n )τ)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ds
+
∫ (1− 12n )τ
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ ds
=
∫ τ
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ ds.
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If Z does not jump in ((1−m/2n) τ, τ ] and t ∈ ((1−m/2n) τ, τ ] then, with the same
reasoning, equation (17) holds on t ∈ ((1−m/2n) τ, τ ]. Suppose now that Z jumps in
((1− (m+ 1)/2n) τ, (1−m/2n) τ ]. Then this interval can be split up into the part before
and the part after the jump, so that, again with the same reasoning as before and since
both X(n) and X are continuous in t, equation (17) still holds.
With probability one there are at most finitely many jump times of Z, so that equa-
tion (17) holds almost surely for all t, and even
sup
t∈[0,τ ]
∣∣X(n)(t)−X(t)∣∣ ≤ sup
t∈[0,τ ]
∫ τ
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ds
=
∫ τ
0
eC·s
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ds a.s.. (18)
7.10 Convergence of D(n) to D
This section proves that D(n)
(
y, t;Z
(n)
t
)
converges almost surely to D
(
y, t;Zt
)
, for fixed
(y, t) ∈ [y1, y2]× [0, τ ]. From equations (12) and (14) it follows that
D
(
y, t;Zt
)
= −
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∂
∂y
FY (t)|Zt (y)
and
D(n)
(
y, t;Z
(n)
t
)
= −
E
[
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∣∣Z(n)t ]
E
[
∂
∂y
FY (t)|Zt (y)
∣∣Z(n)t ] a.s..
Le´vy’s Upward Theorem (see e.g. [33] page 134) can be applied to the denominator and
the numerator of D(n), since both ∂
∂h
∣∣
h=0
FY (t+h)|Zt (y) and
∂
∂y
FY (t)|Zt (y) are bounded (As-
sumption 7.3). Le´vy’s Upward Theorem leads to
E
[
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣Z(n)t
]
→ E
[
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣∣σ (∪∞n=1Z(n)t )
]
a.s.
and
E
[
∂
∂y
FY (t)|Zt (y)
∣∣∣Z(n)t
]
→ E
[
∂
∂y
FY (t)|Zt (y)
∣∣∣∣σ (∪∞n=1Z(n)t )
]
a.s.
as n→∞. The conditioning on σ(∪∞n=1Z(n)t ) can be replaced by conditioning on Zt in both
expressions, because of Lemma A.2 in the Appendix. Since moreover the denominators are
bounded away from 0 (Assumption 7.1c), the Continuous Mapping Theorem implies that,
for fixed (y, t) ∈ [y1, y2]× [0, τ ],
D(n)
(
y, t;Z
(n)
t
)
→ D (y, t;Zt) a.s.. (19)
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7.11 X(n)(t) converges to X(t) and X(t) is measurable
To show that X(n)(t) converges almost surely to X(t) and that X(t) is measurable, the
bound of equation (18) and almost sure convergence of D(n)(y, t) to D(y, t) for (y, t) fixed
of equation (19) are the starting point.
First it is proven that for s fixed, D(n)
(
X(n) (s) , s
)−D (X(n) (s) , s) converges almost
surely to 0. Recall from Section 7.4 that D : [y1, y2] × [t1, t2) → R has a continuous
extension D˜ : [y1, y2] × [t1, t2] → R which is Lipschitz continuous in y with Lipschitz
constant L2/ε+C2L1/ε
2. Recall also that in the proof of Lemma 7.11 in Section 7.8 it was
shown that on Ω′, the set of probability one of equation (15), the same is true for D(n).
Therefore, the pointwise almost sure convergence of D(n)(y, t) to D(y, t) of equation (19)
implies that for fixed s indeed∣∣D(n)(X(n) (s) , s)−D(X(n) (s) , s)∣∣→ 0 a.s. (20)
(for details see Web-Appendix H).
To show that equation (20) implies that the bound of (18) converges almost surely to
0, define
A =
{
(s, ω) ∈ [0, τ ]× Ω : ∣∣D(n)(X(n) (s) , s)−D(X(n) (s) , s)∣∣→ 0} ,
with As its section at s and Aω its section at ω. Then
As =
{
ω ∈ Ω : ∣∣D(n)(X(n) (s) , s)−D(X(n) (s) , s)∣∣→ 0}
has probability one because equation (20). Therefore, using Fubini’s Theorem, with λ the
Lebesgue-measure on [0, τ ],
(λ× P ) (A) =
∫
(0,τ)
P (As) dλ (s)
=
∫
(0,τ)
1dλ (s) = τ.
Also by Fubini’s Theorem,
(λ× P ) (A) =
∫
λ (Aω) dP (ω) ,
so that since λ (Aω) ≤ τ , λ (Aω) = τ P -almost everywhere. This shows that for P -almost
all ω, Aω has measure τ . So for P -almost all ω,
∣∣D (X(n) (s) , s)−D(n) (X(n) (s) , s)∣∣ con-
verges to 0 for λ-almost all s. Moreover, because of expression (12) for D and expres-
sion (14) for D(n) and Assumptions 7.3b and 7.1c, eC·s
∣∣D (·, s)−D(n) (·, s)∣∣ is bounded
by 2eC·τC2/ε on Ω
′. Therefore for almost all ω Lebesgue’s Dominated Convergence Theo-
rem can be applied on the integral of eC·s
∣∣D (X(n) (s) , s)−D(n) (X(n) (s) , s)∣∣ with respect
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to λ,
∫
[0,τ ]
eC·s
∣∣D (X(n) (s) , s)−D(n) (X(n) (s) , s)∣∣ ds, implying that for almost all ω this
integral converges to 0 as n→∞. With equation (18), this implies that
sup
t∈[0,τ ]
∣∣X(n)(t)−X(t)∣∣→ 0 a.s.. (21)
Since the almost sure limit of a sequence of random variables is measurable if the σ-
algebra is complete, measurability of X(t) follows immediately from measurability of the
X(n).
7.12 Conclusion
This section shows that sinceX(n)(t) ∼ Y (t) given Z(n)t (see Section 7.8) andX(n)(t)→ X(t)
a.s. (see Section 7.11), X(t) ∼ Y (t) given Zt. This completes the proof.
It is well-known (see e.g. [32]; Lemma D.10 provides a formal proof for this conditional
version) that X(t) ∼ Y (t) given Zt if
E
[
f (X(t)) |Zt
]− E[f(Y (t))|Zt] = 0 a.s.
for every bounded Lipschitz continuous function f : R → R. Suppose without loss of
generality that f is bounded by 1 and has Lipschitz constant L. Then, using the triangle
inequality,∣∣E [f (X(t)) |Zt]− E[f(Y (t))|Zt]∣∣ ≤ ∣∣∣E [f (X(t)) |Zt]−E [f (X(t)) ∣∣Z(n)t ]∣∣∣
+
∣∣∣E [f (X(t)) ∣∣Z(n)t ]− E [f(X(n)(t))∣∣Z(n)t ]∣∣∣
+
∣∣∣E [f(X(n)(t))∣∣Z(n)t ]− E[f(Y (t))|Zt]∣∣∣ .
Because of Jensen’s inequality, the second term is bounded by E
[∣∣f (X(t))− f(X(n)(t))∣∣ ∣∣Z(n)t ],
which is bounded by E
[
L
∣∣X(t)−X(n)(t)∣∣ ∧ 2∣∣Z(n)t ] since f is Lipschitz continuous with
Lipschitz constant L and bounded by 1. Because X(n)(t) ∼ Y (t) given Z(n)t , the third term
is equal to
∣∣∣E [f(Y (t))∣∣Z(n)t ]−E[f(Y (t))|Zt]∣∣∣. Therefore,∣∣E [f (X(t)) |Zt]−E[f(Y (t))|Zt]∣∣ ≤ ∣∣∣E [f (X(t)) |Zt]− E [f (X(t)) ∣∣Z(n)t ]∣∣∣
+E
[
L
∣∣X(t)−X(n)(t)∣∣ ∧ 2∣∣Z(n)t ]
+
∣∣∣E [f(Y (t))∣∣Z(n)t ]−E[f(Y (t))|Zt]∣∣∣ a.s..(22)
We show that the right hand side converges in probability to zero. On the first and the last
term, Le´vy’s Upward Theorem (see e.g. [33] page 134) can be applied, since the integrands
are bounded by 1. Le´vy’s Upward Theorem leads to
E
[
f (X(t))
∣∣Z(n)t ]→ E [f (X(t)) ∣∣σ (∪∞n=1Z(n)t )]
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and
E
[
f
(
Y (t)
)∣∣Z(n)t ]→ E [f(Y (t))∣∣σ (∪∞n=1Z(n)t )]
as n → ∞. Thus, with Lemma A.2 in the Appendix, both the first and the last term of
equation (22) converge to 0 almost surely. The second term converges to 0 in probability
since it is almost surely non-negative and its expectation converges to 0:
E
(
E
[
L
∣∣X(t)−X(n)(t)∣∣ ∧ 2∣∣Z(n)t ]) = E (L∣∣X(t)−X(n)(t)∣∣ ∧ 2)→ 0
because of Lebesgue’s Dominated Convergence Theorem and the fact thatX(n)(t) converges
almost surely to X(t).
Thus
∣∣E [f (X(t)) |Zt]−E [f (Y (t)) |Zt]∣∣ is bounded by a random variable which con-
verges in probability to 0. Hence, this first random variable is almost surely equal to 0.
Therefore, indeed X(t) mimics Y (t) in the sense that X(t) has the same distribution as
Y (t) given Zt.
7.13 Mimicking counterfactual outcomes: discrete-continuous time
In certain situations there are specific times t with P (t is a jump time of Z) > 0. For
finitely many such times t, the proof in Section 7 can be adapted by adding these finitely
many times to the grid, for each n.
8 Mimicking counterfactual survival outcomes
8.1 Introduction
This section indicates how to prove that X(t) mimics Y (t) in the sense that X(t) has the
same distribution as Y (t) given the covariate- and treatment history Zt, under conditions
aimed at survival. The conditions are similar to the ones in Section 7, but adapted to
survival as the outcome of interest. The proof also follows roughly the same lines as the
one for other outcomes, but some changes are necessary. A full proof can be found in
Web-Appendix B.
If covariates and treatment were measured at time t, it cannot be avoided to include in
Zt whether or not a person was alive at time t: what are a person’s covariates if he or she
is dead? Therefore we include in Z(t) an indicator for whether or not a person is alive at
time t. Thus if a person died at or before time t, the survival time can be read from Zt.
The conditions in Section 7 usually exclude survival as the outcome of interest, since
if the outcome is survival the Support Condition 7.1, saying that all FY (t+h)|Zt have the
same bounded support [y1, y2], will not hold: Zt includes the covariate-measurements and
treatment until time t, and given that a person is dead at time t and given his or her
survival time, the distribution of this survival time cannot have the fixed support [y1, y2],
independent of t. Also given that a person is alive at time t, the survival time often does
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not have the fixed support [y1, y2]: one often expects that t is the left limit of the support,
and obviously the left limit of the support should be greater than or equal to t.
I make two extra assumptions. The first is a straightforward consistency assumption,
stating that stopping treatment after death does not change the survival time. The second
extra assumption states that there is no instantaneous effect of treatment at the time the
person died (notice that the difference between Y (Y ), the outcome with treatment stopped
at the survival time Y , and Y is in treatment at time Y ).
Assumption 8.1. (consistency). Y (t) = Y on {ω : Y ≤ t} ∪ {ω : Y (t) ≤ t}.
Assumption 8.2. (no instantaneous effect of treatment at the time the person died).
Y (t) = Y on {ω : Y = t} ∪ {ω : Y (t) = t} .
As can be expected, these assumptions imply that treatment in the future does not cause
or prevent death at present, see Web-Appendix B.
For survival outcomes this article uses the following minor adaptation of the definition
of D,
D
(
y, t;Zt
)
=


0 if Zt indicates the person is dead at t or y < t
∂
∂h
∣∣
h=0
(
F−1
Y (t+h)|Zt
◦ FY (t)|Zt
)
(y) otherwise, for y > t
limy↓tD
(
y, t;Zt
)
otherwise, for y = t,
(23)
as we explain now. First remark that considering the interpretation of D
(
y, t;Zt
)
as the
infinitesimal effect of a short duration of treatment directly after t on survival, D
(
y, t;Zt
)
should be zero if Zt indicates the person is dead at time t. Although in that case indeed
FY (t+h)|Zt and FY (t)|Zt are almost surely the same for every h ≥ 0, since withholding treat-
ment after death does not change the survival time, F−1
Y (t+h)|Zt
will often not exist. Therefore
if Zt indicates the person is dead at time t, this article just formally definesD
(
y, t;Zt
)
to be
zero. Next consider y < t. Notice that considering the interpretation of D
(
y, t;Zt
)
as the
infinitesimal effect of treatment directly after time t on the survival-quantile y, D
(
y, t;Zt
)
should be zero for y < t since treatment at or after time t should not cause or prevent
death at or before time t, so it should not affect quantiles of the survival curve before time
t. Indeed if Zt indicates that the person is alive at time t, FY (t+h)|Zt (y) = FY |Zt (y) = 0
for y ≤ t for all h ≥ 0, but also for these y, F−1
Y (t+h)|Zt
(y) often does not exist. Therefore,
this article defines D
(
y, t;Zt
)
= 0 for y < t. In order to make D continuous on y ≥ t in
between the jump times of Z, we define D
(
t, t;Zt
)
= limy↓tD
(
y, t;Zt
)
. This limit exists
under the conditions in Section 8.2. It is not necessarily equal to zero.
Notice that the area where D is possibly non-zero is (y, t) ∈ [0,∞) × [0,min {Y, τ}] :
y ≥ t. Therefore if Y < τ , the solution to the differential equation X(t) is equal to Y for
t ∈ [Y, τ ]. An example of such X(t) is shown in Figure 1 (right).
In the case of a survival outcome, right censoring is common. For right censoring,
[26] proposed the artificial censoring estimator. A slight adaptation of this estimator is
presented in Section 8.4.
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8.2 Mimicking counterfactual survival outcomes: assumptions
and result
This section presents precise conditions under which X(t) mimics Y (t), for survival out-
comes, following Section 7.2.1 (Web-Appendix B provides conditions similar to Section 7.2).
We choose versions of FY (t+h)|Zt that (a) are consistent with the fact that treatment after
death is irrelevant, and (b) satisfy all regularity conditions below. These versions are used
in the definition of D for survival outcomes, and everywhere in the proof.
Assumption 8.3. (Regularity conditions).
• (support). There exists a finite number y2 ≥ τ such that
a) If Y > t, all FY (t+h)|Zt, for h ≥ 0 and t ∈ [0, τ ], have support [t, y2].
b) If Y > t, all FY (t+h)|Zt, for h ≥ 0 and t ∈ [0, τ ], have a continuous non-zero
density fY (t+h)|Zt (y) on y ∈ [t+ h, y2].
c) There exists an ε > 0 such that for all ω ∈ Ω and t with Y > t, fY (t)|Zt (y) > ε
for y ∈ [t, y2].
• (smoothness). For every ω ∈ Ω
a) If Z does not jump in (t1, t2) and Y > t1, the restriction of (y, t, h)→ FY (t+h)|Zt (y)
to {(y, t, h) ∈ [t1, y2]× [t1, t2)× R≥0 : y ≥ t+ h} is C1 in (y, t, h).
b) The derivatives of FY (t+h)|Zt (y) (y > t+ h) with respect to y and h are bounded
by constants C1 and C2, respectively.
c) ∂
∂y
FY (t)|Zt(y) and
∂
∂h
∣∣
h=0
FY (t+h)|Zt(y) (y > t) have derivatives with respect to y
which are bounded by constants L1 and L2, respectively.
d) For all ω ∈ Ω and t with Y > t, FY |Zt(y) is continuous and strictly increasing
on its support [t, y2].
Theorem 8.4. Suppose that Regularity Condition 8.3 is satisfied. Then D
(
y, t;Zt
)
as
defined in equation (23) exists. Furthermore, for every ω ∈ Ω there exists exactly one
continuous solution X(t) to dX(t)/dt = D
(
X(t), t;Zt
)
with final condition X (τ) = Y . If
also Assumptions 4.1, 8.1 and 8.2 (consistency and no instantaneous treatment effect at
time of death) are satisfied then this X(t) has the same distribution as Y (t) given Zt for
all t ∈ [0, τ ].
8.3 Outline of the proof
The proof of Theorem 8.4 follows the same lines as the proof of Theorem 7.5. The one
essential difference between survival outcomes and non-survival outcomes is: if Zt indicates
the person is alive at time t, X(t) should be greater than t, since we want X(t) to have
the same distribution as Y (t) given Zt (Y
(t) > t in that case because of Consistency
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Assumption 8.1). This leads to an additional problem in the proof for the continuous-time
case, namely: how to prove that the solution stays above the line y = t for t ∈ [0, Y ]? I
solve this additional problem in Web-Appendix B by showing that, under the assumptions
of Section 8.2, D
(
t, t;Zt
) ≤ 1. In addition, extra technical problems arise because the
smoothness conditions have to be adapted to the survival setting; see Web-Appendix B for
details.
8.4 Survival outcomes and right censoring
In the case of a survival outcome, right censoring is common. [26] proposed the artificial
censoring estimator for administrative censoring. That is censoring due to end-of-follow-up
because the study ends. The idea behind artificial censoring is that, instead of adding X(t)
or X(0) to the model for predicting treatment changes (see Theorem 5.2), one could add
a function X˜(0) of X(0) and the censoring time C, which is observed for all patients. The
artificial censoring estimator treats the censoring time C as a baseline covariate. This is
justified in the case of censoring due to study closure, because in this case C only depends on
the date a patient enrolled in the study. Conditional on the value of Zt−, functions of X(t)
and Zt− are not predictive of treatment changes (Theorem 5.2). Therefore, conditional
on Zt−, X˜(0) is not predictive of treatment changes either. This produces an estimation
procedure for ψ analogous to that in Theorem 5.2, but that allows for right censoring.
We slightly adapt this procedure, and propose to add a function of X(t) and C to the
model for the prediction of treatment changes. In particular, for D as in equation (3) and
for min(Y, C) ≥ t, we propose to add to the prediction model of treatment changes the
function X˜(t, ψ) = min (Xψ(t), C(t, ψ)), with
C(t, ψ) =
{
C if ψ ≥ 0
t+ eψ(C − t) if ψ < 0.
As required, X˜(t, ψ) is a function of Xψ(t) and C. In addition, we will show that both for
the case that ψ ≥ 0 and for the case that ψ < 0, X˜(t, ψ) is observed for all patients. This
follows from the fact that
X˜(t, ψ) = min(X∗(t, ψ), C(t, ψ)), with X∗(t, ψ) = t+
∫ min(Y,C)
t
eψ1no prophylaxis at sds, (24)
which is observed for all patients. For ψ ≥ 0, equation (24) follows from
X˜(t, ψ) = min(t +
∫ Y
t
eψ1no prophylaxis at sds, C)
= min(t +
∫ Y
t
eψ1no prophylaxis at sds, t+
∫ C
t
eψ1no prophylaxis at sds, C)
= min(X∗(t, ψ), C(t, ψ)),
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where for the second equality we used that for ψ ≥ 0, t + ∫ C
t
eψ1no prophylaxis at sds ≥ C. For
ψ < 0, equation (24) follows from
X˜(t, ψ) = min(t +
∫ Y
t
eψ1no prophylaxis at sds, t+ eψ(C − t))
= min(t +
∫ Y
t
eψ1no prophylaxis at sds, t+
∫ C
t
eψ1no prophylaxis at sds, t+ eψ(C − t))
= min(X∗(t, ψ), C(t, ψ)),
where for the second equality we used that for ψ < 0, t+
∫ C
t
eψ1no prophylaxis at sds ≥ t+eψ(C−
t).
For the case that ψ < 0, some patients are “artificially” censored, since if C >
t, C(t, ψ) = t + eψ(C − t) < C. Artificial censoring produces a subclass of the es-
timators considered in Theorem 5.2 allowing ht to depend on ψ: ht,ψ(Xψ(t), Zt−) =
1min(Y,C)≥th˜t(min (Xψ(t), C(t, ψ)) , Zt−) (notice that 1min(Y,C)≥t is a function of Zt−). In
general, one could add to the prediction model for treatment changes any function of
Xψ(t) and C that is observed for all patients. [26] suggests to also consider adding
∆(t, ψ) = 1X˜(t,ψ)≤C(t,ψ) to the model for the prediction of treatment changes. Since both
X˜(t, ψ) and C(t, ψ) are observed for all patients, so is ∆(t, ψ). Thus, the above reasoning
shows that this procedure leads to consistent estimation of the treatment effect as well.
The procedure above can easily be adapted to for example model (5), by replacing
C(t, ψ) accordingly. To be more specific, for that case one could use
C(t, ψ) = t + emim(ψ1,0)+min(ψ2,0)+min(ψ3,0)(C − t).
9 Simulation study
In the simulation study, we calibrated the distributions of the variables and the parameter
values to HIV/AIDS data, perhaps the most salient example of application of structural
nested models in the empirical literature. We focus on the first two years since HIV
diagnosis. Time zero is the time of HIV diagnosis. The outcome variable is the CD4 count,
a commonly used marker of the state of the immune system of HIV-positive patients. The
usual treatment for HIV-positive patients is ART, antiretroviral treatment. ART is not
always initiated immediately after diagnosis. ART initiation time often depends on the last
measured CD4 count. When the CD4 count is at or below 350 copies/ml, HIV-positive
patients are much more likely to initiate ART than when the CD4 count is above 350
copies/ml. Web-Appendix C describes how we generated the data for the simulation study
in detail, including distributions and parameter values. This section provides an overview.
In this simulation study no one is treated at time zero, and once treatment is initiated,
it is never stopped. Y (t) is the counterfactual outcome had treatment been as given in
reality until time t, and continued or initiated after that. For example, if treatment was
initiated by time t for a particular patient, Y (t) is the observed outcome for that patient,
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since he or she was already treated at time t and treatment is never stopped. On the other
hand, if treatment was not initiated by time t, Y (t) is the outcome had treatment been
initiated at time t. Thus, in the definition of Y (t) in Section 2, the switch at time t to
“some kind of baseline treatment regime 0” is, in this case, “treat continuously” from time t
onwards. In the simulations, we study a setting with t ∈ [0, 2]. The subscript t indicates the
treatment initiation time, so for example L1,t indicates (counterfactual) covariates at time
1 under “treatment started at time t”. Similarly, the subscript ∞ indicates (counterfactual)
variables under no treatment. For example, L2,∞ indicates (counterfactual) covariates at
time 2 under no treatment. In the simulation design, the counterfactual covariates L are
as follows:
L0 = L˜0 + e0,
L1,∞ = L˜0 − β0 + e1,∞,
L2,∞ = L˜0 − 2β0 + e2,∞
L1,t = L˜0 − β0 + θ(1− t) + e1,t for t ∈ [0, 1] , and L1,∞ otherwise
L2,t = L˜0 − 2β0 + ψ(2− t) + e2,t,
where L˜0 and the ej,t are random variables with values in R. Notice that (1− t) and (2− t)
are simply the durations of treatment until the respective covariate measurements. We
assume that the ej,t (j = 0, 1, 2) are independent of L˜0, and that the e2,t have a distribution
function which does not depend on t. We also assume that the e2,t are independent of all
previous variables (and of the treatment initiation time, T , described below). In the
simulations, ψ ≥ 0 (a similar study could have been done for ψ < 0). We define Yt = L2,t,
the counterfactual outcome with treatment initiated at time t, which could potentially be
observed at time 2.
We show in Web-Appendix C that the outcome processes adopted in our simulation
study are not rank preserving. This is easily seen because with probability one, two patients
with the same observed data do not have the same value of L˜0.
Suppose that the hazard of the treatment initiation time, T , given the covariate history
at time t and given that treatment was not initiated before time t, is piecewise constant
as follows:
λT (t) =


λ
(0)
0 if L0 > c0 and t ∈ [0, 1]
λ
(0)
1 if L0 ≤ c0 and t ∈ [0, 1]
λ
(1)
0 if L1,∞ > c1 and t ∈ (1, 2]
λ
(1)
1 if L1,∞ ≤ c1 and t ∈ (1, 2],
for constants c0 and c1 in R. Notice that T depends on L˜0, e0,∞, and e1,∞, if λ
(0)
0 6= λ(0)1 or
λ
(1)
0 6= λ(1)1 .
In the simulation study, treatment can be initiated in continuous time, but the covari-
ates are only measured at times 0, 1, and 2, so that the treatment and covariate history
up to time t, Zt, consists of the treatment information up to time t and L0, (L0, L1), or
(L0, L1, L2), depending on whether t ∈ [0, 1), t ∈ [1, 2), or t = 2. In the simulations, treat-
ment affects later outcomes, and time-dependent covariates (L1) which depend on previous
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treatment also predict future treatment and the outcome of interest. This is the type of
setting structural nested models were developed for.
Web-Appendix C shows that for this data generating mechanism,
D(y, t;Zt) = −ψ1untreated at t.
Then, it follows from the definition of Xψ that
Xψ(t) = Y + ψ(min(T, 2)− t)1T>t,
where (min(T, 2) − t)1T>t is the duration of the patient not being on treatment between
time t and time 2.
As shown in Web-Appendix C, a consistent estimator of ψ can be defined as follows. In
the first step, the nuisance parameters
(
λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , λ
(1)
1
)
are estimated using maximum
likelihood theory. In the second step, ψ is estimated as ψˆ = −∑ni=1A1i/∑ni=1A2i, where
A1i = −Yi
(
Zi(0)λˆ
(0)
1 + (1− Zi(0))λˆ(0)0
)
min(Ti, 1)
−Yi
(
Zi(1)λˆ
(1)
1 + (1− Zi(1))λˆ(1)0
)(
1− δ(0)i
)
(min(Ti, 2)− 1)
+Yiδ
(0)
i + Yiδ
(1)
i ,
A2i = −
(
Zi(0)λˆ
(0)
1 + (1− Zi(0))λˆ(0)0
)
min(Ti, 1)min(Ti, 2)
−
(
Zi(1)λˆ
(1)
1 + (1− Zi(1))λˆ(1)0
)(
1− δ(0)i
)
(min(Ti, 2)− 1)2
+δ
(0)
i min(Ti, 2) + δ
(1)
i (min(Ti, 2)− 1),
δ
(0)
i = 1Ti≤1, δ
(1)
i = 11<Ti≤2, Zi(0) = 1L0≤c0, and Zi(1) = 1L1≤c1.
We ran a simulation study with n = 500, 1000, 2000, 5000, and 10000, with 5000
repetitions each. The results are presented in Table 1. As detailed in Web-Appendix C,
setting 1 has the least noise around the signals, and setting 3 the most.
In this simulation study, both for small and large samples, the bias of the estimators is
small. In all three settings and for all sample sizes considered (including the small sample
size n = 100), the MSE of the estimators arises mostly from the variance, not from the
bias. Also, if the true parameter ψ equals 300 as in this simulation study, for n = 500,√
MSE/ψ = 0.04 in setting 1, and 0.08 in setting 3. Thus, the estimates are already
precise in relatively small samples. Because, as shown in the Web-Appendix, the MSE in
this simulation study does not depend on the true parameter, ψ, a larger sample size would
be required to obtain precise estimators of small true parameter values ψ. We conclude
that in this simulation study, continuous-time structural nested models perform extremely
well.
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Table 1: Simulations. Mean Squared Errors (MSE) and bias. 5000 repetitions each.
setting 1 setting 2 setting 3
n MSE
MSE× n
1000
bias MSE
MSE × n
1000
bias MSE
MSE× n
1000
bias
100 747 75 -0.28 1907 191 -0.040 2875 287 -0.39
500 146 73 -0.22 356 178 -0.29 542 271 -0.61
1000 72 72 -0.10 176 176 -0.068 268 268 -0.23
2000 35 70 -0.11 89 179 0.051 138 275 -0.08
5000 14 69 -0.067 35 175 -0.0040 54 268 -0.05
10000 6.6 66 -0.066 18 178 -0.022 27 270 -0.06
10 Discussion
Structural nested models have become a major part of statistical tools for estimation of
the effect of time varying treatments, in the presence of time-dependent confounding by
indication; see e.g. [34] for a discrete-time application, and e.g. [26], [28], [18], [29], [23], [31],
and [11, 10] for continuous-time applications. Structural nested models in continuous time
are useful to estimate the effect of a treatment that can be initiated at any point in time,
and for which a short duration of treatment has a small effect on the outcome of interest.
In contrast with discrete-time structural nested models, in the case of survival outcomes,
the resulting parameter estimates can often be interpreted as rates. So-far, continuous-
time analyses relied on (local) rank preservation. The main result of the current article is
to prove that for continuous-time structural nested models, assumptions about the joint
distributions of counterfactuals or deterministic treatment effects/ (local) rank preservation
are not necessary to “mimic counterfactual outcomes”, and, based on that, to consistently
estimate treatment effects. This article provides a proof for outcomes that are measured
at the end of the study as well as a proof for survival outcomes. Important public health
decisions are based on analyses with continuous-time structural nested models, so it is
important to relax unverifiable and disputable assumptions underlying these analyses.
An interesting topic for future research is to investigate whether the Support Condi-
tions 7.1 or 8.3 can be weakened, for example to an assumption about the support varying
in a differentiable way between the jump times of the covariate- and treatment process Z.
We expect that in that case one has to assume that where Z jumps, the support of Y (t)
given Zt gets smaller or stays the same as t increases (see Figure 2). Otherwise, X(t) may
move out of the support of Y (t) given Zt (recall that X is the solution to a differential
equation with final condition). It is reasonable to assume that the support of Y (t) given
Zt gets smaller or stays the same as t increases, since more information about Z should
not enlarge the range of Y (t).
A problem which may occur without a support condition is that the denominator in
equation (12) (the quotient expression for D) or in equation (13) or (14) (the quotient
expression for D(n)) may tend to 0, which may “blow up” D or D(n). In that case it
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support
of Y (t)
given Zt
✲
tjump time of Z
Figure 2: Example of support of Y (t) given Zt.
might help to assume that there exists a constant C such that (a) for all ω ∈ Ω, t and y,
F−1
Y (t+h)|Zt
◦ FY (t)|Zt (y)− y ≤ C · h, and (b) for all t, y and B ⊂ Zt with P
(
Zt ∈ B
)
> 0,
F−1
Y (t+h)|Zt∈B
◦FY (t)|Zt∈B (y)−y ≤ C ·h. This assumption does not look unreasonable if there
is no “instantaneous treatment effect”. It is to be expected that under this assumption
both D and D(n) are bounded by C.
Based on the results of the current article, [12] shows that also if a semiparametric
Cox model is used to predict treatment changes in Theorem 5.2, the resulting estimating
equations for the treatment effect are unbiased. However, the estimating equations are no
longer of the form of an average of terms that are independent for the different persons.
Thus, consistency and asymptotic normality for this situation constitute interesting topics
for future research.
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Appendix A contains results that are frequently used in the main article. Appendix B
describes Mimicking counterfactual survival outcomes. Appendix C describes details of
the simulation study. Appendix D describes some facts about conditioning. Appendix E
describes a corollary of the Local Inverse Function Theorem. Appendix F describes some
facts about Lipschitz continuity and differentiability. Appendix G describes some theory
about differential equations. Appendix H describes convergence theorems.
A Results that are frequently used
The first theorem is a corollary of a theorem in [4] Chapter 2, see Web-Appendix G.
Theorem A.1. Suppose that I is a closed interval in R, f : I × [y1, y2]→ R is continuous
with for all t ∈ I, f (t, y1) = f (t, y2) = 0 and C : I → [0,∞) is continuous, and suppose
that
|f (t, y)− f (t, z)| ≤ C (t) |y − z| (25)
for all t ∈ I and y, z ∈ [y1, y2]. Then, for every t0 ∈ I and y0 ∈ [y1, y2], there exists a
unique solution y (t) of y′ (t) = f (t, y(t)) with y (t0) = y0, and this solution is defined for
all t ∈ I. Furthermore, y (t) ∈ [y1, y2] for all t ∈ I. Suppose that g : I × [y1, y2] → R is
continuous and z : I → [y1, y2] is a solution of z′ (t) = g (t, z(t)). Then
|y (t)− z (t)|
≤ e
∫ t0
t C(s)ds |y (t0)− z (t0)|+
∫ t0
t
e
∫ s
t
C(η)dη |f (t, z (t))− g (s, z (s))| ds
for all t, t0 ∈ I with t ≤ t0.
The proof of the following lemma can be found in Appendix D.
Lemma A.2. Let X be a random variable with E |X| <∞, and let Zt be a random variable
with values in Z t, the space of cadlag functions on [0, t] provided with the projection σ-
algebra, with P (Z jumps at t) = 0. Then any version of E
[
X|σ(∪∞n=1Z(n)t )], with Z(n)t as
defined in Section 7.6, is also a version of E
[
X|Zt
]
.
B Web-Appendix: Mimicking counterfactual survival
outcomes
B.1 Introduction
For the definition of the infinitesimal shift function D for survival outcomes see Section 8.1.
Also the additional Consistency Assumption 8.1 and Assumption of No instantaneous
treatment effect 8.2 can be found in Section 8.1. Assumption 8.1 implies the obvious fact
that treatment in the future does not cause or prevent death at present:
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Lemma B.1. Under Assumptions 8.1 (consistency),
a) For all h ≥ 0: Y (t+h) = Y on {ω : Y ≤ t} ∪ ∪h≥0
{
ω : Y (t+h) ≤ t}.
b) For all (y, t, h) with y ≤ t + h and h ≥ 0: {ω : Y (t+h) ≤ y} = {ω : Y ≤ y}.
Proof. a): From Assumption 8.1, Y (t) = Y on {ω : Y ≤ t}∪{ω : Y (t) ≤ t}. Thus if Y ≤ t
then Y (t) = Y , and moreover for all h > 0, Y < t+ h, so that, again from Assumption 8.1,
Y (t+h) = Y . If Y (t) ≤ t the same reasoning can be used to prove that Y (t+h) = Y . If for
some h > 0, Y (t+h) ≤ t then also Y (t+h) ≤ t + h, so that, again from Assumption 8.1,
Y (t+h) = Y .
b): For y ≤ t + h and h ≥ 0, {ω : Y (t+h) ≤ y} = {ω : Y (t+h) ≤ y} ∩ {Y (t+h) ≤ t+ h} =
{ω : Y ≤ y} because of Assumption 8.1. ✷
Henceforth, this article will only use versions of conditional distributions which are consis-
tent with Lemma B.1 in the sense that FY (t+h)|Zt (y) = FY |Zt (y) for all y ≤ t + h, h ≥ 0,
and ω ∈ Ω.
Notice that with definition (23) of D, the area where D is possibly non-zero is (y, t) ∈
[0,∞)× [0,min {Y, τ}] : y ≥ t. Therefore if Y < τ , the solution to the differential equation
X(t) is equal to Y for t ∈ [Y, τ ]. An example of such X(t) is shown in Figure 1, right
panel.
B.2 Mimicking counterfactual survival outcomes: assumptions
and result
This section provides precise conditions under which X(t) mimics Y (t) in the sense that
X(t) has the same distribution as Y (t) given Zt, for survival outcomes. We choose versions
of FY (t+h)|Zt which are consistent with Lemma B.1 and which satisfy all regularity conditions
below. These versions are used in the definition of D of equation (23), and everywhere else
in this section.
Section 8.1 indicated why it is not reasonable to assume that the conditional distribution
of the survival time has the fixed support [y1, y2] given any covariate- and treatment history
Zt. If a person is alive at time t, one often expects that t is the left limit of the support.
Therefore, this article assumes that
Assumption B.2. (support). There exists a finite number y2 ≥ τ such that
a) For all ω ∈ Ω and t with Y > t, all FY (t+h)|Zt for h ≥ 0 have support [t, y2].
b) For all ω ∈ Ω and t with Y > t, all FY (t+h)|Zt for h ≥ 0 have a continuous non-zero
density fY (t+h)|Zt (y) on y ∈ [t+ h, y2].
c) There exists an ε > 0 such that for all ω ∈ Ω and t with Y > t, fY (t)|Zt (y) > ε for
y ∈ [t, y2].
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Next consider the smoothness conditions in Section 7. It does not seem reasonable
to assume that FY (t+h)|Zt (y) is continuously differentiable with respect to h and y on
(h, y) ∈ [0,∞)× [t, y2] since for y ≤ t+ h, FY (t+h)|Zt (y) = FY |Zt (y) (Lemma B.1b). Thus,
the derivative of FY (t+h)|Zt (y) with respect to h is likely not to exist at y = t + h (and is
equal to zero for y < t+ h). Also the derivative of FY (t+h)|Zt (y) with respect to y may not
exist at y = t + h, because of the different treatment before and after t + h. For survival
outcomes, the smoothness conditions 7.2–7.4 are therefore replaced by:
Assumption B.3. (continuous derivatives). For ω ∈ Ω fixed,
a) If Y > t then FY (t+h)|Zt (y) restricted to {(h, y) ∈ [0,∞)× [t, y2] : y ≥ t + h} is C1 in
(h, y).
b) If Z does not jump in (t1, t2) and Y > t1 then both
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y) and
∂
∂y
FY (t)|Zt (y)
are continuous in (y, t) on {(y, t) ∈ [t1, y2]× [t1, t2) : y > t} and can be continuously
extended to {(y, t) ∈ [t1, y2]× [t1, t2] : y ≥ t}.
Assumption B.4. (bounded derivatives).
a) There exists a constant C1 such that for all t, h ≥ 0 and y > t + h, for ω ∈ Ω with
Y > t,
∂
∂y
FY (t+h)|Zt (y) ≤ C1.
b) There exists a constant C2 such that for all t, h ≥ 0 and y > t + h, for ω ∈ Ω with
Y > t, ∣∣∣ ∂
∂h
FY (t+h)|Zt (y)
∣∣∣ ≤ C2.
Assumption B.5. (Lipschitz continuity).
a) There exists a constant L1 such that for all t and y, z ∈ (t, y2], for ω ∈ Ω with Y > t,∣∣∣ ∂
∂y
FY (t)|Zt (y)−
∂
∂z
FY (t)|Zt (z)
∣∣∣ ≤ L1 |y − z| .
b) There exists a constant L2 such that for all t and y, z ∈ (t, y2], for ω ∈ Ω with Y > t,∣∣∣∣ ∂∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)−
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (z)
∣∣∣∣ ≤ L2 |y − z| .
Assumption B.6. (smoothness). For all ω ∈ Ω and t with Y > t, FY |Zt(y) is continuous
in y.
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Theorem B.7. Suppose that Regularity Conditions B.2–B.5 are satisfied. ThenD
(
y, t;Zt
)
as defined in equation (23) exists. Furthermore for every ω ∈ Ω there exists exactly one
continuous solution X(t) to dX(t)/dt = D
(
X(t), t;Zt
)
with final condition X (τ) = Y . If
also Assumptions 4.1, 8.1 and 8.2 (consistency and no instantaneous treatment effect at
time of death) are satisfied then this X(t) has the same distribution as Y (t) given Zt for
all t ∈ [0, τ ].
The simpler regularity conditions, comparable with Section 7.2.1 for non-survival out-
comes, can be found in Section 8.2.
B.3 Existence of and a different expression for D
If Y ≤ t, D (y, t;Zt) = 0 by definition (23). Thus we can concentrate on ω ∈ Ω with
Y > t. If y > t, Corollary 7.7 can be applied on Fh (y) = FY (t+h)|Zt (y) with y0 = y and
U0,y0∩{h ≥ 0} = [0, y − t)×(t, y2], because of Assumptions B.3a and B.2c. Thus for y > t,
D as defined in equation (23) exists, and it is equal to
D
(
y, t;Zt
)
=
(
∂
∂h
∣∣∣∣
h=0
F−1
Y (t+h)|Zt
)(
FY (t)|Zt (y)
)
= −
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∂
∂y
FY (t)|Zt (y)
. (26)
D
(
t, t;Zt
)
is by definition (23) equal to the limit as y ↓ t of this D (y, t;Zt), which exists
because of Assumptions B.2c and B.3a.
B.4 Existence and uniqueness of X(t)
If Zt indicates the person is alive at time t and X(t) has the same distribution as Y
(t) given
Zt, we should have that X(t) stays above t (Y
(t) > t in that case because of Consistency
Assumption 8.1). In order to prove that X(t) stays indeed above t if the person is alive at
time t, we prove that D
(
t, t;Zt
) ≤ 1.
Lemma B.8. Under Assumptions B.2 and B.3a, if Y > t then D
(
t, t;Zt
) ≤ 1.
Proof. We start with some ideas, which are made precise below. Intuition says that D not
only measures the increase of quantiles when treatment is prolonged but also the decrease
of quantiles when treatment is withheld. Thus quantiles y seem to approximately move to
y−hD (y, t;Zt) when treatment is withheld between t and t+h. If quantiles near t move
down to t with speed greater than 1 when treatment is withheld starting from h it seems
like these quantiles will end up below t when treatment is withheld at time t. However, if
treatment is withheld starting from t this does not cause death at or before time t, so the
quantiles above t should stay above t. This leads to a contradiction. The following makes
this precise.
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Fix ω ∈ Ω and fix t for which Y > t. Recall from Section B.3 that a := limy↓tD
(
y, t;Zt
)
exists. We need to prove that a ≤ 1. Suppose that a > 1. It is shown that this leads to a
contradiction. Notice that because of the chain rule, for y > t+ h,
∂
∂h
(
F−1
Y (t)|Zt
◦ FY (t+h)|Zt
)
(y) =
(
F−1
Y (t)|Zt
)′ (
FY (t+h)|Zt (y)
) ∂
∂h
FY (t+h)|Zt (y)
=
∂
∂h
FY (t+h)|Zt (y)
F ′
Y (t)|Zt
(
F−1
Y (t)|Zt
◦ FY (t+h)|Zt (y)
) (27)
exists and is continuous in (h, y) for y > t + h with a continuous extension to
{(h, y) ∈ [0,∞)× [t, y2] : y ≥ t+ h} because of Assumptions B.3a and B.2c. Notice that
for h = 0 this expression is equal to −D (y, t;Zt) because of expression (26) for D. Thus
the limit of (27) for h = 0 and y ↓ t is equal to −a. This can be compared with the
intuitive idea that quantiles y approximately move to y − hD (y, t;Zt) when treatment is
withheld between t and t+ h.
Now choose δ = a−1
2
, which is greater than 0 since we assumed that a > 1. By
continuity of (27) in (h, y) there exists an open neighbourhood U(0,t) of (0, t) such that
on
{
(h, y) ∈ U(0,t) : y > t + h and h ≥ 0
}
, the expression (27) above is not further than
δ away from −a. Thus there also exist h0 > 0 and y0 > t such that for h ∈ [0, h0],
y ≤ y0 and y > t + h, (27) is not further than δ away from −a. Choose h1 ∈ [0, h0] with
t+ (1 + δ) h1 ≤ y0, and define y1 = t + (1 + δ)h1.
Notice that since y1 > t+ h1,
t < F−1
Y (t)|Zt
◦ FY (t+h1)|Zt (y1)
(informally this is about withholding treatment in the future not causing death at present,
which we wanted to use; formally this follows e.g. from Assumption B.2a and b). Moreover,
for y = y1, the derivative (27) exists on h ∈ [0, h1], since for h ∈ [0, h1], y1 = t+(1 + δ) h1 >
t+ h1 ≥ t+ h. Thus by Taylor expansion there exist an h˜1 ∈ [0, h1] with
F−1
Y (t)|Zt
◦ FY (t+h1)|Zt (y1) = y1 + h1
∂
∂h
∣∣∣∣
h=h˜1
F−1
Y (t)|Zt
◦ FY (t+h)|Zt (y1) .
Combining this it follows that
t < y1 + h1
∂
∂h
∣∣∣∣
h=h˜1
F−1
Y (t)|Zt
◦ FY (t+h)|Zt (y1)
for some h˜1 ∈ [0, h1]. Rewriting this leads to
− h1 ∂
∂h
∣∣∣∣
h=h˜1
F−1
Y (t)|Zt
◦ FY (t+h)|Zt (y1) < y1 − t = (1 + δ)h1. (28)
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For
(
h˜1, y1
)
, (27) is not further than δ away from −a, since h˜1 ∈ [0, h0], y1 ≤ y0 and
y1 > t + h1 ≥ t+ h˜1, so that
∂
∂h
∣∣∣∣
h=h˜1
F−1
Y (t)|Zt
◦ FY (t+h)|Zt (y1) ∈ (−a− δ,−a + δ) .
Therefore the expression on the left hand side of equation (28) lies in the interval
((a− δ)h1, (a+ δ)h1). Equation (28) thus implies that (a− δ) h1 < (1 + δ)h1, so a <
1 + 2δ, so a−1
2
< δ. This is in contradiction with our choice of δ, which was δ = a−1
2
. ✷
Fix ω for the rest of this section. Just as in Section 7.4, it suffices to prove existence
and uniqueness of X(t) with final condition on any interval between jumps of Z, because
with probability one Z jumps only finitely many times. Hence suppose that Z does not
jump in (t1, t2) and that t1 is either a jump time of Z or 0 and that t2 is either a jump
time of Z or τ .
If Zt1 indicates that the person is dead at t1, D is identically 0 on [t1, τ ] and X(t) exists,
X(t) is unique, and X(t) is identically Y on [t1, τ ].
If Zt1 indicates that the person is alive at t1, I use Corollary G.4 to prove existence and
uniqueness ofX(t). Notice thatD
(
y, t;Zt
)
is continuous on {(y, t) ∈ [t1, y2]× [t1, t2) : y ≥ t}
because of equation (26) and Assumptions B.3b and B.2c. However, the differential equa-
tion with X(t) has a final condition at the upper end of the interval [t1, t2). Just as in
Section 7.4, we define the continuous extension D˜ of D on [t1, y2]× [t1, t2] : y ≥ t, which ex-
ists because of Assumption B.2c and the extension-assumption in Assumption B.3b. Just as
in Section 7.4, D˜ is Lipschitz continuous in y on {(y, t) ∈ [t1, y2]× [t1, t2) : y > t} with Lips-
chitz constant L2/ε+C2L1/ε
2. The same constant works on {(y, t) ∈ [t1, y2]× [t1, t2] : y ≥ t}
by continuity. Because of Lemma B.8 above, D
(
t, t;Zt
) ≤ 1 for all t. Thus Corollary G.4
gives existence and uniqueness of a continuous solution X(t) to the differential equation
with D˜, with X (t) ≥ t if Y > t.
B.5 Mimicking counterfactual survival: discrete time
This section considers the situation where Z, the available information on the treatment-
and covariate process, can be fully described by its values at finitely many fixed points
0 = τ0 < τ1 < τ2 < . . . < τK < τK+1 = τ . At any time at which a person’s covariates are
measured, one has to include in the covariates whether or not a person was alive at that
time (otherwise, the covariates would be ill-defined). Hence we assume that Zt includes
whether or not a person was alive at τ1, . . . , τp(t), with τp(t) the last τk before or at time t.
For simplicity we pose differentiability conditions and restrictions on the support of
Y (t) given Zτk for t ≥ τk that are similar to the continuous-time case. Notice that if τk
is the lower support limit of FY |Zτk
, then τk is also the lower support limit of FY (t)|Zτk
for
all t > τk: if τk is the lower support limit of FY |Zτk
then, because of Lemma B.1b, for all
h > 0 and all δ > 0, P
(
Y (τk+h) ≤ τk − δ
)
= P (Y ≤ τk − δ) = 0, and, again because of
Lemma B.1b, for all h > 0 and all 0 < δ < h, P
(
Y (τk+h) ≤ τk + δ
)
= P (Y ≤ τk + δ) > 0.
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In most cases τk will then also be the lower support limit of FY (τk)|Zτk
, unless by stopping
treatment at time τk the person stays alive with probability one for a certain period of time,
while if treatment is not stopped at time τk the hazard of dying is non-zero immediately
after time τk. For the same reasons as in the continuous-time case, differentiability is only
assumed for y ≥ t. Assumption 7.8 is replaced for survival outcomes by:
Assumption B.9. (smoothness). Suppose that there exists a y2 > τ such that for k =
0, . . . , K and t ∈ [τk, τk+1] there exist conditional distribution functions FY (t)|Zτk which are
consistent with Lemma B.1 and such that if Zτk indicates that the person is alive at time
τk:
a) For every t ∈ [τk, τk+1], FY (t)|Zτk has support [τk, y2].
b) FY (t)|Zτk
(y) is continuous in (y, t) on (y, t) ∈ R× [τk, τk+1].
c) FY (t)|Zτk
(y) is C1 in (y, t) on (y, t) ∈ [τk, y2] × [τk, τk+1] : y > t with a C1 extension to
(y, t) ∈ [τk, y2]× [τk, τk+1] : y ≥ t .
d) For t ∈ [τk, τk+1), ∂∂yFY (t)|Zτk (y) is strictly positive on y ∈ [t, y2].
Throughout Section B.5, fixed versions of FY (t)|Zτk
(y) are used satisfying Assump-
tion B.9. Since Zt contains the same information as Zτk for t ∈ [τk, τk+1), we can and will
choose the same versions when conditioning on Zt.
In this discrete-time case Zt contains no indicator for death or alive at time t except for
if t is one of the τk’s. However, also in this case X(t) should be above t for t < Y : for such
Y , X(t) should not play the role of Y (t)’s less than t. The reason for this is, intuitively, that
if Y (t) < t, Y (t) = Y < t, and if also Y ’s greater than t would play this role there would
be too many of them. It will be shown explicitly that there exists a solution X(t) with
X(t) > t for Y > t. Hence the following analogue of Theorem 7.9 for survival outcomes:
Proposition B.10. Suppose that the treatment- and covariate process Z can be fully de-
scribed by its values at finitely many fixed points 0 = τ0 < τ1 < τ2 < . . . < τK < τK+1 = τ ,
and suppose also that Assumption B.9 is satisfied. Then D
(
y, t;Zt
)
exists for all t. Fur-
thermore if also Assumptions 4.1, 8.1 and 8.2 (consistency and no instantaneous treat-
ment effect at time of death) are satisfied, then there exists a continuous solution X(t) to
dX(t)/dt = D
(
X(t), t;Zt
)
with final condition X (τ) = Y and with X(t) > t if Y > t, for
which X (t) has the same distribution as Y (t) given Zt.
Proof. For t ∈ [τk, τk+1) and y > t, Lemma 7.7 can be applied on Ft(y) = FY (t)|Zτk (y) with
y0 = y, because of Assumptions B.9 c and d. Thus D
(
y, t;Zt
)
as defined in equation (23)
exists for y > t and
D
(
y, t;Zt
)
= −
∂
∂t
FY (t)|Zτk
(y)
∂
∂y
FY (t)|Zτk
(y)
. (29)
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By definition, D
(
t, t;Zt
)
is equal to limit of (29) for y ↓ t, which exists because of As-
sumptions B.9 c and d.
Under Assumption B.9 one can explicitly write down a solution to the differential
equation dX(t)/dt = D
(
X(t), t;Zt
)
with final condition X(τ) = Y , as follows. For the
moment consider ω ∈ Ω fixed. Define τp(ω) as the last τk before the survival time Y . In the
following, F
Y
(τp(ω))|Zτp(ω)
will denote the distribution function FY (τk)|Zτk
for which k = p (ω).
It will not denote a distribution function conditional on p (ω). Define X˜(t) as follows. For
t ≥ τp(ω)+1, define X˜(t) = Y . For t < τp(ω)+1, t ∈ [τk, τk+1), define
X˜(t) = F−1
Y (t)|Zτk
◦ F
Y
(τk+1)|Zτk
◦ . . . ◦ F−1
Y
(τp(ω))|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y ) .
This X˜(t) is well-defined under Assumption B.9 a and b.
It is first shown that if Y > t then also X˜(t) is greater than t. First, consider t ∈[
τp(ω), Y
) ∩ [0, τ ]. For such t, Y > t, so
F
Y
(τk(ω)+1)|Zp(ω)
(Y ) > F
Y
(τp(ω)+1)|Zp(ω)
(t) ,
since because of Assumption B.9 a, F
Y
(τp(ω)+1)|Zp(ω)
is strictly increasing on its support[
τp(ω), y2
]
, which includes both t and Y . Because of Lemma B.1b, the right hand side of
this expression is equal to FY (t)|Zp(ω) (t). Hence
F
Y
(τk(ω)+1)|Zp(ω)
(Y ) > FY (t)|Zp(ω) (t) ,
so that since F−1
Y (t)|Zτp(ω)
is strictly increasing on [0, 1] (Assumption B.9 a),
X˜(t) = F−1
Y (t)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y ) > F−1
Y (t)|Zτp(ω)
◦ FY (t)|Zp(ω) (t) .
The right hand side is equal to t, since t ∈ [τp(ω), y2] and FY (t)|Zτp(ω) is strictly increasing
on
[
τp(ω), y2
]
(Assumption B.9 a). Thus indeed X˜(t) > t for t ∈ [τp(ω), Y ).
To show that X˜(t) is also greater than t for other t < Y , I use induction, starting with
k = p (ω)− 1 and ending with k = 0. It thus needs to be proven that if t ∈ [τk, τk+1) and
X˜ (τk+1) > τk+1 then X˜ (t) > t. So suppose that t ∈ [τk, τk+1) and that X˜ (τk+1) > τk+1.
Notice that X˜ (τk+1) > τk ≥ t, so that
F
Y
(τk+1)|Zτk
(
X˜ (τk+1)
)
> F
Y
(τk+1)|Zτk
(t) ,
since because of Assumption B.9 a, F
Y
(τk+1)|Zτk
is strictly increasing on its support [τk, y2],
which includes both t and X˜(τk+1). Because of Lemma B.1b, the right hand side of this
expression is equal to FY (t)|Zτk
(t). Therefore
F
Y
(τk+1)|Zτk
(
X˜ (τk+1)
)
> FY (t)|Zτk
(t) ,
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so that, because F−1
Y (t)|Zτk
is strictly increasing on [0, 1] (Assumption B.9 a),
X˜(t) = F−1
Y (t)|Zτk
◦ F
Y
(τk+1)|Zτk
(
X˜ (τk+1)
)
> F−1
Y (t)|Zτk
◦ FY (t)|Zτk (t) .
The right hand side of this expression is equal to t, since t ∈ [τk, y2] and FY (t)|Zτk is strictly
increasing on [τk, y2] (Assumption B.9 a). It follows that indeed X˜(t) > t if Y > t.
Next, it is shown that X˜(t) is a continuous solution to X˜ ′(t) = D
(
X˜(t), t;Zt
)
with
final condition X˜ (τ) = Y . First consider t ≥ τp(ω)+1. For these t, D
(
y, t;Zt
)
= 0, so X˜(t)
should be equal to Y ; and indeed X˜(t) is equal to Y . For t ∈ [Y, τp(ω)+1) it is also true
that D
(
y, t;Zt
)
= 0, so X˜(t) should be equal to Y . Because of Lemma B.1b,
FY (t)|Zτp(ω)
(Y ) = F
Y
(τp(ω)+1)|Zτp(ω)
(Y ) ,
so X˜(t) is indeed equal to Y .
To show that X˜(t) satisfies X˜ ′(t) = D
(
X˜(t), t;Zt
)
on
[
τp(ω), Y
)
, notice that for h ≥ 0
small, since FY (t)|Zτp(ω)
is continuous (Assumption B.9 b),
X˜ (t + h) = F−1
Y (t+h)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y )
= F−1
Y (t+h)|Zτp(ω)
◦ FY (t)|Zτp(ω) ◦ F
−1
Y (t)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y )
= F−1
Y (t+h)|Zτp(ω)
◦ FY (t)|Zτp(ω)
(
X˜(t)
)
.
This expression is differentiable at h = 0 with derivative D
(
X˜(t), t;Zt
)
, since, as shown
before, X˜(t) > t. Thus indeed X˜(t) satisfies X˜ ′(t) = D
(
X˜(t), t;Zt
)
on
[
τp(ω), Y
)
.
I still need to prove continuity of X˜(t) at t = Y , but it is easier to show continuity
on
[
τp(ω), τp(ω)+1
]
, so we show continuity of X˜(t) on
[
τp(ω), τp(ω)+1
]
. From Van der Vaart
[32] Lemma 21.2, Fn converges weakly to F if and only if F
−1
n (t) → F−1(t) at every t
where F−1 is continuous. Notice that because of Assumption B.9 b, FY (t)|Zτp(ω)
converges
weakly to FY (t0)|Zτp(ω)
as t ∈ [τp(ω), τp(ω)+1] → t0 for any t0 ∈ [τp(ω), τp(ω)+1]. Moreover,
because of Assumption B.9 a, F−1
Y (t0)|Zτk
is continuous on (0, 1]. Therefore, F−1
Y (t)|Zτp(ω)
(x)→
F−1
Y (t0)|Zτp(ω)
(x) as t ∈ [τp(ω), τp(ω)+1]→ t0, for every x ∈ (0, 1]. Thus also
X˜(t) = F−1
Y (t)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y )→ F−1
Y (t0)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y )
as t ∈ [τp(ω), τp(ω)+1] → t0 (notice that FY (τp(ω)+1)|Zτp(ω) (Y ) > 0 since Y (τp(ω)+1) given Zτp(ω)
has support
[
τp(ω), y2
]
because of Assumption B.9a). For t0 ∈
[
τp(ω), τp(ω)+1
)
, the right hand
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side of this expression is equal to X˜(t0), which implies continuity of X˜(t) on
[
τp(ω), τp(ω)+1
)
.
For t0 = τp(ω)+1, the right hand side of this expression is equal to
F−1
Y
(τp(ω)+1)|Zτp(ω)
◦ F
Y
(τp(ω)+1)|Zτp(ω)
(Y ),
which is equal to Y since Y is in the support of F
Y
(τp(ω)+1)|Zτp(ω)
(Assumption B.9 a) and
F
Y
(τp(ω)+1)|Zτp(ω)
is strictly increasing on its support (Assumption B.9 a). That implies
continuity of X˜(t) at τp(ω)+1.
That also for k < p(ω), X˜(t) satisfies X˜ ′(t) = D
(
X˜(t), t;Zt
)
on [τk, τk+1) and that
X˜(t) is continuous on [τk, τk+1] follows the same way as in the previous paragraph, starting
from the fact that for such k and t ∈ [τk, τk+1), X˜(t) = F−1Y (t)|Zτk ◦ FY (τk)|Zτk
(
X˜ (τk+1)
)
.
Next it is proven that X˜(t) has the same distribution as Y (t) given Zt. For t = τ ,
X˜ (τ) = Y , so that X˜(t) has the same distribution as Y (τ) given Zτ because of Assump-
tion 4.1 (consistency). For the induction step, suppose that for t ∈ [τk, τ ] (for k = K + 1
read t = τ), X˜(t) has the same distribution as Y (t) given Zt. To show: for t ∈ [τk−1, τk),
X˜(t) has distribution function FY (t)|Zt = FY (t)|Zτk−1
. If Zτk indicates that the person is
dead at τk then X˜(t) = Y = Y
(t) because of Lemma B.1a, so certainly X˜(t) ∼ Y (t) given
Zτk . If Zτk indicates that the person is alive at τk, then
X˜(t) = F−1
Y (t)|Zτk−1
◦ F
Y (τk)|Zτk−1
(
X˜ (τk)
)
and the rest of the proof can be copied from the proof of Theorem 7.9. ✷
B.6 Discretization and choices of conditional distributions
The construction of the Z
(n)
τk
can be copied from Section 7.6. Notice that, by construction,
Z
(n)
τk
includes whether or not a person is alive at τk.
Notation B.11. At this point we choose conditional distributions P
Zτk |Z
(n)
τk
. In addition,
we choose
F
Y (t)|Z
(n)
τk
(y) =
∫
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z) (30)
to be the version of the conditional distribution function of Y (t) given Z
(n)
τk
which is used
in the rest of the proof, and similarly for Y instead of Y (t). If s ∈ (τk, τk+1) we take the
same version for F
Y (t)|Z
(n)
s
; this is possible because in that case Z
(n)
s = Z
(n)
τk
.
These distributions are consistent with Lemma B.1 in the sense that for y ≤ t and for all
ω ∈ Ω, FY (t)|Zτk (y) = FY |Zτk (y). This follows immediately from the fact that all FY (t)|Zτk
are consistent with Lemma B.1 in this sense.
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B.7 Existence of and two expressions for D(n)
We prove existence of D(n) as defined in equation (23) for the discretized situation of
Section B.6. Moreover, as in Section 7.7, two useful formula’s for D(n) are derived.
The same way as in Section 7.7 it follows that for t ≥ τk and y ∈ (t, y2], if Z(n)τk indicates
the person is alive at τk,
∂
∂h
∣∣∣∣
h=0
(
F−1
Y (t+h)|Z
(n)
τk
◦ F
Y (t)|Z
(n)
τk
)
(y) = −
∫
∂
∂h
∣∣
h=0
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)∫
∂
∂y
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)
.
The limit for y ↓ t exists because of Assumption B.3a and Assumptions B.4 and B.2b (the
proof is the same as the proof for continuity of this expression in (y, t) in Section 7.8).
Hence with the versions of F
Y (t)|Z
(n)
s
chosen in Notation B.11,
D(n)
(
y, t;Z
(n)
t
)
=


0 if Z
(n)
t indicates the person is dead at t or y < t
∂
∂h
∣∣
h=0
(
F−1
Y (t+h)|Z
(n)
t
◦ F
Y (t)|Z
(n)
t
)
(y) otherwise for y > t
limy↓tD
(
y, t;Zt
)
otherwise for y = t
(31)
exists for every t. Moreover, for t ∈ [τk, τk+1) and y > t,
D(n)
(
y, t;Z
(n)
t
)
= −
∫
∂
∂h
∣∣
h=0
FY (t+h)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)∫
∂
∂y
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z)
. (32)
This expression is similar to expression (13) for D(n) for non-survival outcomes.
Expression (14) for non-survival outcomes takes a different form for survival outcomes.
Just as for expression (14), I restrict to the Ω′ defined in equation (15) in Section 7.7, a set
of probability one on which conditional probabilities given Z
(n)
t are uniquely defined. For
n and ω ∈ Ω′ such that Z(n)t indicates the person is alive at the last τk at or before time t,
it will be shown that for y > t,
D(n)
(
y, t;Z
(n)
t
)
= −
E
[
1{alive at t}
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∣∣Z(n)t ]
E
[
1{alive at t}
∂
∂y
FY (t)|Zt (y)
∣∣Z(n)t ] . (33)
The indicator of being alive at time t is new as compared to the non-survival case of
Section 7.
To prove equation (33), first restrict to ω ∈ Ω′. Suppose that Z(n)τk indicates the person
is alive at τk and suppose that t ≥ τk. Then for h ≥ 0 and y ≥ t+ h,
P
(
Y (t+h) ≤ y∣∣Z(n)τk ) = P (Y (t+h) ≤ y∣∣Z(n)τk , Y ∈ (τk, t])P (Y ∈ (τk, t] ∣∣Z(n)τk )
+
∫
zt: alive at t
FY (t+h)|Zt=zt (y) dPZt|Z(n)τk
(zt) .
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Given that Y ≤ t, Lemma B.1a gives that Y (t+h) = Y ≤ t, and, since y ≥ t, also
Y (t+h) ≤ t ≤ y. It follows that
P
(
Y (t+h) ≤ y∣∣Z(n)τk ) = P (Y ∈ (τk, t] ∣∣Z(n)τk )+
∫
zt
1{alive at t} FY (t+h)|Zt=zt (y)dPZt|Z(n)τk
(zt) .
(34)
To derive equation (33) from equation (34), Corollary 7.7 is applied on
Fh (y) = P
(
Y ∈ (τk, t]
∣∣Z(n)τk )+
∫
zt
1{alive at t} FY (t+h)|Zt=zt (y)dPZt|Z(n)τk
(zt) ,
for y > t, with y0 = y. We check the conditions of Corollary 7.7. Just as in Section 7.7,
on y > t + h, h ≥ 0, Fh (y) is differentiable with respect to y and h with derivatives∫
1{alive at t} F
′
Y (t+h)|Zt=zt
(y)dP
Zt|Z
(n)
τk
(zt) and
∫
1{alive at t}
∂
∂h
FY (t+h)|Zt=zt(y) dPZt|Z(n)τk
(zt), re-
spectively. Also the same way as in Section 7.7, it follows that these derivatives are
continuous in (y, h). That F ′0 (y) is non-zero follows from Assumption B.2c, if the prob-
ability that the person is alive at time t given Z
(n)
τk
is non-zero. Indeed the probability
that the person is alive at time t given Z
(n)
τk
is non-zero, since given any Zτk indicating
that the person is not dead at τk, Y , which has the same distribution as Y
(τ) given Zτk
because of Assumption 4.1, has support [τk, y2] (Assumption B.2a). Thus the conditions
of Corollary 7.7 are satisfied, and equation (33) follows from equation (34).
B.8 Applying the discrete-time result
Lemma B.12. Suppose that Regularity Conditions B.2–B.5 and Assumptions 4.1, 8.1
and 8.2 (consistency and no instantaneous treatment effect at time of death) are satisfied.
Then for every n there exists a continuous solution X(n)(t) to the differential equation in
the discretised setting,
d
dt
X(n)(t) = D(n)
(
X(n)(t), t;Z
(n)
t
)
,
with final condition X(n) (τ) = Y . X(n) (t) is almost surely unique. Moreover, X(n)(t) > t
if Y > t. Furthermore, X(n) (t) has the same conditional distribution as Y (t) given Z
(n)
t .
The proof of this lemma is different from the proof in Section 7.8, because of the different
assumptions for the discrete-time case if the outcome is survival.
Proof. Fix n. First, it is shown that there exists a continuous solution X(n) with X(n)(t) >
t if Y > t for which X(n)(t) has the same conditional distribution as Y (t) given Z
(n)
t , using
Proposition B.10. We thus need to check that the versions of the conditional distributions
F
Y (t)|Z
(n)
τk
of Y (t) given Z
(n)
τk
chosen in Notation B.11 satisfy Assumption B.9.
Section B.6 already showed that the conditional distributions F
Y (t)|Z
(n)
τk
(y) chosen in
Notation B.11 are consistent with Lemma B.1. We check Assumption B.9 a–d. If Z
(n)
τk
indicates that the person is alive at time τk then:
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a) F
Y (t)|Z
(n)
τk
has support [τk, y2] since all FY (t)|Zτk=z
have support [τk, y2] (Assumption B.2
a).
b) F
Y (t)|Z
(n)
τk
(y) = F
Y (τk+(t−τk))|Z
(n)
τk
(y) is continuous in (y, t) on (y, t) ∈ R× [τk, τk+1] : y ≥ t
because of Assumption B.3 a and Lebesgue’s dominated convergence theorem, since all
FY (t)|Zτk
are bounded by 1. For y ≤ t, FY (t)|Zτk (y) = FY |Zτk (y) because of Lemma B.1,
which is continuous in (y, t) because of Assumption B.6. Therefore, the same is true
for the version of F
Y (t)|Z
(n)
τk
(y) chosen in Notation B.11.
c) F
Y (t)|Z
(n)
τk
(y) = F
Y
(τk+(t−τk))|Z
(n)
τk
(y) is C1 in (y, t) on (y, t) ∈ [τk, y2] × [τk, τk+1] : y ≥ t
because all FY (t)|Zτk
(y) are C1 there (Assumption B.3 a), and all derivatives are bounded
there (Assumption B.4), which follows with the same reasoning as for F
Y (t+h)|Z
(n)
τk
as in
Section 7.7: integration and differentiation can be interchanged here.
d) Under c) it was shown that for y ≥ t,
∂
∂y
F
Y (t)|Z
(n)
τk
(y) =
∫
∂
∂y
FY (t)|Zτk=z
(y) dP
Zτk |Z
(n)
τk
(z) .
Because of Assumption B.2 b this is greater than 0. ✷
Continuity of D(n) on {(y, t) ∈ (τk, y2]× (τk, τk+1) : y > t} with a continuous exten-
sion D˜(n) to {(y, t) ∈ [τk, y2]× [τk, τk+1] : y ≥ t} follows from equation (32), similar to Sec-
tion 7.8. Also similar to Section 7.8, D˜(n)(y, t) is Lipschitz continuous in y on
{(y, t) ∈ [τk, y2]× [τk, τk+1] : y ≥ t} for ω ∈ Ω′ of equation (15), and uniqueness of X(n)
on Ω′ follows from Corollary G.4.
B.9 Bounding the difference between X and X(n) in terms of D
and D(n)
X(n) and X satisfy the differential equations with the continuous extensions of D(n) and D,
D˜(n) and D˜, respectively, on the closed intervals [t1, t2] as in Section 7.9, because if Y ≥ t,
both X(t) ≥ t (Section B.4) and X(n)(t) ≥ t (Section B.8). D˜ is Lipschitz continuous in
y on these intervals, as shown at the end of Section B.4. Therefore it follows in a similar
way as in Section 7.9 but with Corollary G.4 instead of Theorem A.1 that almost surely
∣∣X(n)(t)−X(t)∣∣ ≤ ∫ τ
t
eC·(s−t)
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ds (35)
and
sup
t∈[0,τ ]
∣∣X(n)(t)−X(t)∣∣ = ∫ τ
0
eC·s
∣∣D(X(n) (s) , s)−D(n)(X(n) (s) , s)∣∣ds, (36)
with C = L2/ε+ C2L1/ε
2.
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B.10 Convergence of D(n) to D
This section proves that for all (y, t) fixed, D(n)
(
y, t;Z
(n)
t
)
converges almost surely to
D
(
y, t;Zt
)
. First, consider Zt indicating the person is dead at time t. Then, D
(
y, t;Zt
)
=
0. Note that the probability the person died at exactly time t is 0. Therefore, almost
surely, for n large enough Z
(n)
t indicates the person is dead at the last τk at or before time
t. Thus, also D(n)
(
y, t;Z
(n)
t
)
= 0, so D(n) converges to D. For y < t, D
(
y, t;Zt
)
and all
D(n)
(
y, t;Z
(n)
t
)
are 0. Therefore it suffices to consider y ≥ t and ω and t for which Zt
indicates the person is alive at time t. We start by proving that for y > t, D(n)
(
y, t;Z
(n)
t
)
converges almost surely to D
(
y, t;Zt
)
. Equation (26) implies that if Zt indicates the
person is alive at time t, for y > t
D
(
y, t;Zt
)
= −
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∂
∂y
FY (t)|Zt (y)
,
and equation (33) implies that, since the person is alive at the last τk at or before time t,
for y > t
D(n)
(
y, t;Z
(n)
t
)
= −
E
[
1{alive at t}
∂
∂h
∣∣
h=0
FY (t+h)|Zt (y)
∣∣Z(n)t ]
E
[
1{alive at t}
∂
∂y
FY (t)|Zt (y)
∣∣Z(n)t ] .
We will apply Le´vy’s Upward Theorem (see e.g. Williams [33] page 134), which is allowed
since ∂
∂h
∣∣
h=0
FY (t+h)|Zt (y) and
∂
∂y
FY (t)|Zt (y) are bounded because of Assumption 7.3. Le´vy’s
Upward Theorem leads to
E
[
1{alive at t}
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣Z(n)t
]
→ E
[
1{alive at t}
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣∣σ (∪∞n=1Z(n)t )
]
a.s. (37)
and
E
[
1{alive at t}
∂
∂y
FY (t)|Zt (y)
∣∣∣Z(n)t
]
→ E
[
1{alive at t}
∂
∂y
FY (t)|Zt (y)
∣∣∣∣σ (∪∞n=1Z(n)t )
]
a.s.. (38)
Replacing the conditioning on σ
(∪∞n=1Z(n)t ) by conditioning on Zt in (37) and (38) is allowed
because of Lemma A.2. Since for these Zt,
E
[
1{alive at t}
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣Zt
]
= 1{alive at t}E
[
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt (y)
∣∣∣Zt
]
and
E
[
1{alive at t}
∂
∂y
FY (t)|Zt (y)
∣∣∣Zt
]
= 1{alive at t}E
[
∂
∂y
FY (t)|Zt (y)
∣∣∣Zt
]
,
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this implies that for y > t fixed
D(n)
(
y, t;Z
(n)
t
)
→ D (y, t;Zt) a.s.. (39)
To prove that also
D(n)
(
t, t;Z
(n)
t
)
→ D (t, t;Zt) a.s., (40)
We will apply Lemma H.1. To do that it suffices to have Lipschitz continuity of all D(n)
and D in y with the same Lipschitz constant, and if that is the case equation (40) follows.
That D is Lipschitz continuous in y with Lipschitz constant 1
ε
L2 +
C2
ε2
L1 was shown in
Section B.4. That D(n) is Lipschitz continuous in y with Lipschitz constant 1
ε
L2+
C2
ε2
L1 on
Ω′ was shown in Section B.8.
B.11 X(n)(t) converges to X(t) and X(t) is measurable
Equations (36), (39) and (40) are the starting point here. If Y ≥ t, both X(t) ≥ t
(Section B.4) and X(n)(t) ≥ t (Section B.8), so that the rest of the proof can be copied
from Section 7.11.
B.12 Conclusion
This section can be copied from Section 7.12.
B.13 Mimicking counterfactual outcomes: discrete-continuous
time
This section can be copied from Section 7.13.
C Web-Appendix: A simulation study
C.1 Introduction
This appendix provides further details on the design of the simulation study of Section 9.
In the simulation study, we calibrated the distributions of the variables and the parameter
values to HIV/AIDS data, perhaps the most salient example of application of structural
nested models in the empirical literature. For details, see Section C.4.
Web-Appendix C is organized as follows. Section C.2 presents the counterfactual out-
comes and the treatment initiation process. The outcomes and treatment initiation are
designed so that treatment predicts intermediate covariates which in turn predict future
treatment: the type of setting structural nested models were designed for. Continuous-
time structural nested models can be adopted when the treatment is initiated in continuous
time. Consequently, in the simulations we impose that treatment decisions are adopted
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continuously in time. Section C.3 shows that our setting does not impose (local) rank
preservation. In Section C.4, the distributions and parameters are calibrated to real data
on HIV/AIDS. Section C.5 derives the parametric form of the infinitesimal shift-function
D. Section C.6 derives the solution to the differential equation (8): the “mimicking” vari-
able Xψ(t) of Section 4. Section C.7 describes the estimators. Section C.8 describes the
results of the simulation study.
C.2 An additive model for treatment effect, and the treatment
initiation process
In this simulation study no one is treated at time zero, and once treatment is initiated,
it is never stopped. Y (t) is the counterfactual outcome had treatment been as given in
reality until time t, and continued or initiated after that. For example, if treatment was
initiated by time t for a particular patient, Y (t) is the observed outcome for that patient,
since he or she was already treated at time t and treatment is never stopped. On the other
hand, if treatment was not initiated by time t, Y (t) is the outcome had treatment been
initiated at time t. Thus, in the definition of Y (t) in Section 2, the switch at time t to
“some kind of baseline treatment regime 0” is, in this case, “treat continuously” from time t
onwards. In the simulations, we study a setting with t ∈ [0, 2]. The subscript t indicates the
treatment initiation time, so for example L1,t indicates (counterfactual) covariates at time
1 under “treatment started at time t”. Similarly, the subscript ∞ indicates (counterfactual)
variables under no treatment. For example, L2,∞ indicates (counterfactual) covariates at
time 2 under no treatment. In the simulation design, the counterfactual covariates L are
as follows:
L0 = L˜0 + e0,
L1,∞ = L˜0 − β0 + e1,∞,
L2,∞ = L˜0 − 2β0 + e2,∞
L1,t = L˜0 − β0 + θ(1− t) + e1,t for t ∈ [0, 1] , and L1,∞ otherwise
L2,t = L˜0 − 2β0 + ψ(2− t) + e2,t,
where L˜0 and the ej,t are random variables with values in R. Notice that (1− t) and (2− t)
are simply the durations of treatment until the respective covariate measurements. We will
assume that the ej,t (j = 0, 1, 2) are independent of L˜0, and that the e2,t have a distribution
function which does not depend on t. We will also assume that the e2,t are independent
of all previous variables (and of the treatment initiation time, T , described below). In the
simulations, ψ ≥ 0 (a similar study could have been done for ψ < 0). We define Yt = L2,t,
the counterfactual outcome with treatment initiated at time t, which could potentially be
observed at time 2.
T will be the treatment initiation time, with T = ∞ if treatment was not initiated in
the time interval [0, 2]. The treatment initiation time T determines which of the above
variables is observed. Y = L2 = YT no matter when treatment is started. L1 = L1,T if
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T ≤ 1 and L1 = L1,∞ if T > 1. T also determines what are the Y (t), with Y (t) = Yt if
T > t and Y (t) = YT if T ≤ t.
Suppose that the hazard of the treatment initiation time T , given the covariate history
at time t and given that treatment was not initiated before time t, is piecewise constant
as follows:
λT (t) =


λ
(0)
0 if L0 > c0 and t ∈ [0, 1]
λ
(0)
1 if L0 ≤ c0 and t ∈ [0, 1]
λ
(1)
0 if L1,∞ > c1 and t ∈ (1, 2]
λ
(1)
1 if L1,∞ ≤ c1 and t ∈ (1, 2],
for constants c0 and c1 in R. Notice that T depends on L˜0, e0,∞, and e1,∞, if λ
(0)
0 6= λ(0)1 or
λ
(1)
0 6= λ(1)1 .
In the simulation study, treatment can be initiated in continuous time, but the covari-
ates are only measured at times 0, 1, and 2, so that the treatment and covariate history
up to time t, Zt, consists of the treatment information up to time t and L0, (L0, L1), or
(L0, L1, L2), depending on whether t ∈ [0, 1), t ∈ [1, 2), or t = 2.
In the simulations, treatment affects later outcomes, and time-dependent covariates
(L1) which depend on previous treatment also predict future treatment and the outcome
of interest. This is the type of setting structural nested models were developed for.
C.3 No rank preservation in the simulations
The outcomes described in Section C.2 are not rank preserving. For two patients with the
same treatment history, the complete observed data are the same if the sum of L˜0 and
the ej,T (for j = 0, 1, 2) are all three the same. However, under an alternative treatment,
the outcomes for two patients with the same observed data can be different. In fact, in
this simulation study, they are different with probability one. This is easily seen because
with probability one, the value of L˜0 is not the same for these two patients. Under rank
preservation, two patients with the same observed data ((L0, L1, L2, T, Y ) the same for
both patients) also would have had the same outcomes had they both followed the same
alternative treatment (Yt the same for both patients). Thus, rank preservation does not
hold in this simulation study.
C.4 Choice of parameter values in the simulation study
In the simulation study, we calibrate the distributions of the variables and the parameter
values to HIV/AIDS data. We focus on the first two years since HIV diagnosis. Time zero
is the time of HIV diagnosis. The outcome variable is the CD4 count, a commonly used
marker of the state of the immune system of HIV-positive patients. The usual treatment
for HIV-positive patients is ART, antiretroviral treatment. ART is not always initiated
immediately after diagnosis. ART initiation time often depends on the last measured CD4
count. When the CD4 count is at or below 350 copies/ml, HIV-positive patients are much
more likely to initiate ART than when the CD4 count is above 350 copies/ml. Thus, in
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the simulation study we choose c1 = c0 = 350. Intermediate CD4 counts are affected by
previous treatment and predict both future treatment and the final outcome Y , the CD4
count at year two.
Based on a histogram of the first measured CD4 count in the AIEDRP data (Acute
Infection and Early Disease Research Program, see [7]), and based on the median and IQR
estimates of the first measured CD4 count in [1], we choose to simulate L0 so that the
square root of L0 is approximately normal. According to [1], “the median CD4 count at
presentation increased from 256 cells/mm3 (interquartile range, 96 − 455 cells/mm3) to
317 cells/mm3 interquartile range (IQR), 135 − 517 cells/mm3) from 1997 to 2007.” For
our first scenario, we choose
√
L˜0 ∼ N (17, 82). We simulate ek ∼ N (0, 202), so it has a
relatively small standard deviation. Based on a preliminary simulation with one million
observations, the median L0 in this simulation scenario is 294, IQR 135−501; these values
are close to the empirical values.
In our simulations, the probability of treatment initiation in the first year is 0.70 for
patients with a baseline CD4 count below 350 and 0.30 for patients with a baseline CD4
count above 350. While in clinical practice, patients with a higher CD4 count are less
likely to be treated, with 350 often used as a cut-off, the 0.70 and 0.30 values are not
chosen based on data, because treatment guidelines have been changing considerably over
time in the past few years and differ by country ([19, 35]). The simulation values of the
treatment initiation parameters ensure that all patients have a considerable probability
of being untreated and also a considerable probability of being treated. If patients with
specific covariates are either always treated or always untreated, we cannot estimate the
effect of treatment for these patients (because it is impossible to distinguish the treatment
effect from the reason why the treatment was given). Thus, in the simulations we choose
λ
(0)
0 = −log(1− 0.3) and λ(0)1 = −log(1− 0.7). For treatment initiation during the second
year, we choose the same parameter values: λ
(1)
0 = −log(1− 0.3) and λ(1)1 = −log(1− 0.7).
This implies that for any untreated covariate history, the probability of ever initiating
treatment is .3 + (.7 × .3) to .7 + (.3 × .7), or 0.51 to 0.91. Based on the estimates in
[15] and [16], the median CD4 count could increase by about 200 between ART initiation
and one year later, and the effect of one year of ART is about 12 × 25 = 300. Therefore,
we choose: β0 = 100, and θ0 = ψ0 = 300. Table 1, setting 1 describes the results of this
simulation scenario.
In a second simulation scenario, setting 2 in Table 1, we introduce more variation
around the signals. In the second scenario, we increase the variance of ek to 200
2, with√
L˜0 ∼ N (17, 62). Based on a preliminary simulation with one million observations, the
median L0 in scenario 2 is 313, IQR 125− 501. The other parameters are as in scenario 1.
In the third simulation study, setting 3 in Table 1, we introduce even more variation
around the signals. In the third scenario, we increase the variance of ek to 300
2, with√
L˜0 ∼ N (18, 32). Based on a preliminary simulation with one million observations, the
median L0 in scenario 3 is 333, IQR 119− 545. The other parameters are as in scenario 1.
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C.5 Calculating the infinitesimal shift function D
This section calculates D for the simulation study. First note that if treatment had already
started by time t, there is no difference between Y (t) and Y (t+h), so that D(y, t;Zt) = 0
for all y. Therefore, we focus on calculating D for Zt such that T > t. Let t be given.
We only need to derive FY (t+h)|Zt(y) for h > 0 small. Therefore, we restrict calculations to
h ∈ [t, t+h0] such that [t+h0] lies within either [0, 1) or [1, 2), depending on which of these
two intervals contains t. Let e2 be any random variable which is independent of Zt and
the treatment process and which has the same distribution as the e2,t. Denote the actual
duration of treatment until time t+ h by the random variable cum(t+ h). We derive:
FY (t+h)|Zt(y) = P
(
Y (t+h) ≤ y|Zt
)
= P
(
L˜0 − 2β0 + ψ
(
cum(t+ h) + 2− (t + h)
)
+ e2,min(T,t+h) ≤ y|Zt
)
= P
(
L˜0 − 2β0 + ψ
(
cum(t+ h) + 2− (t + h)
)
+ e2 ≤ y|Zt
)
= E
[
P (L˜0 − 2β0 + ψ
(
cum(t+ h) + 2− (t+ h)
)
+ e2 ≤ y|Zt, e2, L˜0)|Zt
]
= E
[
P (cum(t+ h) ≤ 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h)|Zt, e2, L˜0)|Zt
]
.(41)
Next, since we restrict to Zt such that T > t, we have that 0 ≤ cum(t + h) ≤ h, and
because of the way the treatment initiation process was simulated, for x ∈ [0, h],
P
(
cum(t+ h) ≤ x|Zt, e2, L˜0
)
= P
(
cum(t+ h) ≤ x|Zt
)
= P
(
(t + h)− T ≤ x|Zt
)
= P
(
T − t ≥ h− x|Zt
)
=
{
e−λ
(⌊t⌋)
0 (h−x) if L⌊t⌋ > c⌊t⌋
e−λ
(⌊t⌋)
1 (h−x) if L⌊t⌋ ≤ c⌊t⌋,
(42)
where ⌊t⌋ is the floor of t, the largest integer less than or equal to t. In the first line of (42)
we use that, in our simulation design, the rate of treatment initiation does not depend on
(e2, L˜0), given Zt, which includes L⌊t⌋.
For T > t, L⌊t⌋ ≤ c⌊t⌋, and λ1 = λ(⌊t⌋)1 , since cum(t+ h) ∈ [0, h] for patients with T > t,
53
it follows from equations (41) and (42) that
FY (t+h)|Zt(y) = 0 · P
(
1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) < 0|Zt
)
+1 · P
(
1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) > h|Zt
)
+E
[
e−λ1(h−(
1
ψ
(y−e2−L˜0+2β0)−(2−t−h)))|
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) ∈ (0, h), Zt
]
·P
(
1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) ∈ (0, h)|Zt
)
= P
(
(y − e2 − L˜0 + 2β0)− ψ(2− t) > 0|Zt
)
+E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) ∈ (0, h), Zt
]
·P
(
(y − e2 − L˜0 + 2β0)− ψ(2− t) ∈ (−ψh, 0)|Zt
)
= P
(
Y (t) < y|Zt
)
+E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) ∈ (0, h), Zt
]
·P ((y − Y (t)) ∈ (−ψh, 0)|Zt)
= P
(
Y (t) ≤ y|Zt
)
+E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t− h) ∈ (0, h), Zt
]
·P (Y (t) ∈ (y, y + ψh)|Zt)
= FY (t)|Zt(y)
+E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t) ∈ (−h, 0), Zt
]
·
(
FY (t)|Zt(y + ψh)− FY (t)|Zt(y)
)
. (43)
In our simulation study, (L˜0, e2) has a continuous conditional distribution f(L˜0,e2)|Zt . There-
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fore, conditional on a value of Zt such that T > t, we have that
E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t) ∈ (−h, 0), Zt
]
=
∫ ∞
−∞
dl˜0
∫ (−(2−t)+h)ψ+y−l˜0+2β0
−(2−t)ψ+y−l˜0+2β0
de2f(L˜0,e2)|Zt(l˜0, e2)e
−λ1(− 1ψ (y−e2−L˜0+2β0)+(2−t)),
which is continuously differentiable in h ≥ 0 for (y, t, Zt) fixed, with some derivative,
g(y, t, h, Zt). Therefore, equation (43) implies that
∂
∂h
FY (t+h)|Zt(y) = g(y, t, h, Zt)
(
FY (t)|Zt(y + ψh)− FY (t)|Zt(y)
)
+E
[
e−λ1(−
1
ψ
(y−e2−L˜0+2β0)+(2−t))
| 1
ψ
(y − e2 − L˜0 + 2β0)− (2− t) ∈ (−h, 0), Zt
]
·ψfY (t)|Zt(y + ψh),
where fY (t)|Zt is the density of Y
(t) given Zt. Notice that since T > t, Y
(t) = Yt given Zt,
and the density fY (t)|Zt = fYt|Zt exists and is continuous. Letting h ↓ 0, it follows that
∂
∂h
∣∣∣∣
h=0
FY (t+h)|Zt(y) = ψfY (t)|Zt(y).
Clearly,
∂
∂y
FY (t)|Zt(y) = fY (t)|Zt(y).
Hence, because of equation (12),
D(y, t;Zt) = −ψ1untreated at t. (44)
The same derivation can be used for L⌊t⌋ > c⌊t⌋.
In fact, it can be shown that if the counterfactual covariates and the counterfactual
outcomes are as in this simulation study, D = −ψ1untreated at t if T has a continuous con-
ditional density fT |Zt(y) given Zt for y ∈ [t, t + h0] for some h0 > 0. This is beyond the
scope of the current article. In future work, we also plan to address multidimensional ψ,
as well as parameterizing D for survival outcomes.
C.6 Calculating Xψ(t)
As a consequence of Section 4 and equation (44), it follows that Xψ(t) is the solution to
dXψ(t)/dt = −ψ1untreated at t
55
with end condition Xψ(2) = Y (recall that time 2 is the time the outcome is measured).
Therefore,
Xψ(t) = Y + ψ(min(T, 2)− t)1T>t,
where (min(T, 2) − t)1T>t is the duration of the patient not being on treatment between
time t and time 2.
C.7 Estimating equations when treatment initiation follows a
piecewise exponential model
Suppose that we know that treatment initiation follows a piecewise exponential model,
with parameter depending on a discretized covariate, measured at time 0 and time 1. In
the simulation, we assume
λT
(
t|Zt
)
=


λ
(0)
0 if L0 > c0 and t ∈ [0, 1]
λ
(0)
1 if L0 ≤ c0 and t ∈ [0, 1]
λ
(1)
0 if L1 > c1 and t ∈ (1, 2]
λ
(1)
1 if L1 ≤ c1 and t ∈ (1, 2]
for known constants c0 and c1 in R, and for λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , and λ
(1)
1 unknown values in
R. To select from the many possible estimating equations for ψ provided in Theorem 5.2,
we follow the approach of [26], which was proved to lead to consistent estimation in [13]
provided the main result of the current article holds true. Below we explain why this
approach works in the context of this simulation study. [26] proposed to add α times a
function of Xψ(t) and Zt− to the model for treatment initiation λT , and find the parameter
ψ such that adding this function has no effect on the estimated hazard (that is, the ψ that
leads to αˆ = 0); that particular ψ will be the estimate ψˆ. The underlying observation
for this procedure is that given Zt−, for the true ψ, Xψ(t) should not help to predict
treatment changes (Section 5). Adding α times a function of Xψ(t) and Zt− to λT can be
done in many different ways. For simplicity of calculations, we choose to add αXψ(0), a
function of Xψ(t) and Zt−, to the model for treatment initiation λT in the time interval
[0, 1], and αXψ(1) to the model for treatment initiation λT in the time interval [1, 2], both
in a way similar to a Cox proportional hazards component: as a factor eαXψ(0) and eαXψ(1),
respectively. Let δ
(0)
i = 1Ti≤1, δ
(1)
i = 11<Ti≤2, Zi(0) = 1L0≤c0, and Zi(1) = 1L1≤c1. The
partial likelihood for the model extended with Xψ as described above is
L
(
λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , λ
(1)
1 , α
)
=
n∏
i=1
(
λ
(0)
Zi(0)
eαXψ,i(0)
)δ(0)i
e
−λ
(0)
Zi(0)
e
αXψ,i(0)min(Ti,1)
n∏
i=1
(
λ
(1)
Zi(1)
eαXψ,i(1)
)δ(1)i
e
−λ
(1)
Zi(1)
(
1−δ
(0)
i
)
e
αXψ,i(1)(min(Ti,2)−1).
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The log likelihood is:
logL
(
λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , λ
(1)
1 , α
)
=
n∑
i=1
δ
(0)
i log
(
λ
(0)
Zi(0)
eαXψ,i(0)
)
− λ(0)
Zi(0)
min(Ti, 1)e
αXψ,i(0)
+δ
(1)
i log
(
λ
(1)
Zi(1)
eαXψ,i(1)
)
−
(
1− δ(0)i
)
λ
(1)
Zi(1)
(min(Ti, 2)− 1)eαXψ,i(1)
=
n∑
i=1
δ
(0)
i Zi(0)logλ
(0)
1 − Zi(0)λ(0)1 (min(Ti, 1))eαXψ,i(0)
+
n∑
i=1
δ
(0)
i (1− Zi(0))logλ(0)0 − (1− Zi(0))λ(0)0 min(Ti, 1)eαXψ,i(0)
+
n∑
i=1
δ
(1)
i Zi(1)logλ
(1)
1 −
(
1− δ(0)i
)
Zi(1)λ
(1)
1 (min(Ti, 2)− 1)eαXψ,i(1)
+
n∑
i=1
δ
(1)
i (1− Zi(1))logλ(1)0 −
(
1− δ(0)i
)
(1− Zi(1))λ(1)0 (min(Ti, 2)− 1)eαXψ,i(1)
+
n∑
i=1
δ
(0)
i αXψ,i(0) + δ
(1)
i αXψ,i(1).
Following [13], to calculate ψˆ, we take the derivative of this expression with respect to
(λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , λ
(1)
1 , α), then set α = 0, and solve for (λˆ
(0)
0 , λˆ
(0)
1 , λˆ
(1)
0 , λˆ
(1)
1 , ψˆ); as indicated
below, consistency of the estimator will follow from Theorem 5.2. We obtain the estimating
equations:
0 =
∂
∂λ
(0)
0 , λ
(0)
1 , λ
(1)
1 , λ
(1)
0 , α
∣∣∣∣∣
α=0
logL
(
λ
(0)
0 , λ
(0)
1 , λ
(1)
0 , λ
(1)
1 , α
)
=
n∑
i=1


δ
(0)
i (1−Zi(0))
λ
(0)
0
− (1− Zi(0))min(Ti, 1)
δ
(0)
i Zi(0)
λ
(0)
1
− Zi(0)min(Ti, 1)
δ
(1)
i (1−Zi(1))
λ
(1)
0
−
(
1− δ(0)i
)
(1− Zi(1))(min(Ti, 2)− 1)
δ
(1)
i Zi(1)
λ
(1)
1
−
(
1− δ(0)i
)
Zi(1)(min(Ti, 2)− 1)
Gi(ψ)


, (45)
with
Gi(ψ) = −
(
Zi(0)λ
(0)
1 + (1− Zi(0))λ(0)0
)
(min(Ti, 1))Xψ,i(0)
−
(
Zi(1)λ
(1)
1 + (1− Zi(1))λ(1)0
)(
1− δ(0)i
)
(min(Ti, 2)− 1)Xψ,i(1)
+δ
(0)
i Xψ,i(0) + δ
(1)
i Xψ,i(1). (46)
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According to Theorem 5.2, with ht(X(t), Zt−) = X(0) for t ∈ [0, 1] and ht(X(t), Zt−) =
X(1) for t ∈ (1, 2], these are indeed unbiased estimating equations. Solving the estimating
equations, in the first step, the λ’s are estimated by their maximum likelihood estimates
without adding Xψ to the model:


λˆ
(0)
0
λˆ
(0)
1
λˆ
(1)
0
λˆ
(1)
1

 =


∑n
i=1 δ
(0)
i (1−Zi(0))∑n
i=1(1−Zi(0))min(Ti,1)∑n
i=1 δ
(0)
i Zi(0)∑n
i=1 Zi(0)min(Ti ,1)∑n
i=1 δ
(1)
i (1−Zi(1))∑n
i=1(1−Zi(1))1Ti>1(min(Ti,2)−1)∑n
i=1 δ
(1)
i Zi(1)∑n
i=1 Zi(1)1Ti>1(min(Ti,2)−1)


. (47)
General theory, see e.g. [32], says these estimates for the hazard are consistent and asymp-
totically normal. In the second step, ψ is then estimated by plugging these estimates for
the hazard in
∑n
i=1Gi(ψ), with Gi(ψ) as in equation (46), and solving for ψ. In the simula-
tions, Xψ is linear in ψ, see Section C.6, and thus
∑n
i=1Gi(ψ) is also linear in ψ. Therefore,
solving for ψ requires solving a linear, in our case even one-dimensional, equation. If the
coefficient before ψ is non-zero, there is a unique solution ψˆ. In addition, the expectation
of Gi(ψ) at the true λ is linear in ψ, so EGi(ψ) = 0 has a unique solution if the coefficient
on ψ in the linear equation EGi(ψ) is non-zero, which guarantees consistency and asymp-
totic normality ([32] Chapter 5). We conclude from Section C.6 and equation (46) that a
consistent estimator of ψ can be defined as ψˆ = −∑ni=1A1i/∑ni=1A2i, where
A1i = −Yi
(
Zi(0)λˆ
(0)
1 + (1− Zi(0))λˆ(0)0
)
min(Ti, 1)
−Yi
(
Zi(1)λˆ
(1)
1 + (1− Zi(1))λˆ(1)0
)(
1− δ(0)i
)
(min(Ti, 2)− 1)
+Yiδ
(0)
i + Yiδ
(1)
i
and
A2i = −
(
Zi(0)λˆ
(0)
1 + (1− Zi(0))λˆ(0)0
)
min(Ti, 1)min(Ti, 2)
−
(
Zi(1)λˆ
(1)
1 + (1− Zi(1))λˆ(1)0
)(
1− δ(0)i
)
(min(Ti, 2)− 1)2
+δ
(0)
i min(Ti, 2) + δ
(1)
i (min(Ti, 2)− 1).
We choose to add Xψ(0) to the prediction model for treatment changes in the time
interval [0, 1] and to add Xψ(1) in the time interval (1, 2]. Optimally choosing the function
of Xψ(t) and Zt− to add to the prediction model for treatment changes is an interesting
topic for future research.
Algebra shows that in this simulation study, the bias and the MSE of ψˆ do not depend
on the values of ψ0 or θ0 (for θ0 this is easily seen by noticing that the estimators depend
only on the Yi, the Ti (which depend only on pre-treatment variables), and pre-treatment
variables). These algebraic calculations were confirmed by simulating scenario 2 with
θ0 = ψ0 = 300 replaced by θ0 = ψ0 = 100, which lead to the same bias and MSE as
scenario 2 itself. Therefore, we did not vary ψ0 or θ0 in the simulation study.
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C.8 Results of the simulation study
We ran a simulation study with n = 500, 1000, 2000, 5000, and 10000, and 5000 repetitions
each. The results for the three settings described in Section C.4 are presented in Section 9,
Table 1.
In this simulation study, both for small and large samples, the bias of the estimators is
small. In all three settings and for all sample sizes considered (including the small sample
size n = 100), the MSE of the estimators arises mostly from the variance, not from the
bias. Also, if the true parameter ψ equals 300 as in this simulation study, for n = 500,√
MSE/ψ = 0.04 in setting 1, and 0.08 in setting 3. Thus, the estimates are already precise
in relatively small samples. Because, as we noted before, the MSE in this simulation study
does not depend on the true parameter ψ, a larger sample size would be required to obtain
precise estimators of small true parameter values ψ.
Table 1 also shows that the mean squared error decreases appropriately as the sample
size increases. In all three settings, the MSE times the sample size is roughly constant.
This indicates that the large-sample theory in Section C.7 (which follows from the fact
that the estimating equations are unbiased) provides a reasonable approximation for the
rate of convergence of the estimator in finite samples.
We conclude that adding Xψ(0) to the prediction model for treatment changes in the
time interval [0, 1] and adding Xψ(1) in the time interval (1, 2], as described in Section C.7,
provides estimators with good finite-sample properties in this simulation study.
Finally, to confirm consistency of the estimators, we ran a simulation study with one
dataset and n equal to one million, in all three settings. This resulted in ψˆ = 299.545 for
setting 1, ψˆ = 299.863 for setting 2, and ψˆ = 299.673 for setting 3, all very close to the
true value of ψ = 300 in the simulation study.
We conclude that in this simulation study, continuous-time structural nested models
perform extremely well.
D Web-Appendix: Some facts about conditioning
The following definition and two theorems on existence and uniqueness of conditional
distributions can be found in Bauer [2] Section 10.3, in a different formulation. The first is
a definition of conditional distributions. A conditional distribution of a random variable X
with values in R is more than just a set of conditional probabilities P (X ≤ x|G) for x ∈ R:
it is also a probability measure on R. Conditional probabilities always exist; a conditional
distribution always exists e.g. if X takes values in R, but not in general. Conditional
probabilities are almost surely unique; under conditions the same is true for conditional
distributions.
Definition D.1. Let X : (Ω,F) → (X ,A) be a random variable on a probability space
(Ω,F , P ) with values in a measurable space (X ,A). Let G ⊂ F be a sub-σ-algebra. Then
PX|G : Ω×A → R is a conditional distribution of X given G if
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a) ∀A ∈ A: ω → PX|G (ω,A) is a version of P (X ∈ A|G), i.e. it is G-measurable and
∀G ∈ G: ∫
G
PX|G (ω,A)dP (ω) =
∫
G
1A (X) dP = P
(
G ∩X−1 (A)) .
b) PX|G (ω, ·) is a probability measure on (X ,A).
If X takes values in R the distribution function belonging to the probability measure PX|G
is often denoted by FX|G .
Theorem D.2. Let X : (Ω,F) → (X ,A) be a random variable on a probability space
(Ω,F , P ) with values in a measurable space (X ,A). Suppose that A is a countably generated
σ-algebra and G ⊂ F is a sub-σ-algebra. If PX|G and P ∗X|G are two conditional distributions
of X given G then they are almost surely the same in the sense that there exists a P -null
set N ∈ F such that for all ω ∈ Ω \N and all A ∈ A,
PX|G (ω,A) = P
∗
X|G (ω,A) .
A topological space E is called Polish if it has a countable dense subset and there exists
a metric that generates the topology and for which the space is complete. An example of
a Polish space is Rk with the usual topology.
Theorem D.3. Let X : (Ω,F) → (E,B (E)) be a random variable on a probability space
(Ω,F , P ) with values in a Polish space E with its Borel-σ-algebra. Then for every σ-algebra
G ⊂ F there exists a conditional distribution PX|G.
The next theorem is very useful in combination with Theorem D.3. Suppose that Z is
a random variable on (Ω,F) with values in the space of cadlag functions on [a, b], D[a, b],
equipped with the σ-algebra generated by the coordinate projections. Then Theorems D.3
and D.4 imply that for any σ-algebra G ⊂ F , Z has a conditional distribution given G.
Theorem D.4. Suppose that a, b ∈ R are finite. Then D [a, b] with the Skorohod topology
is a Polish space. Furthermore, the σ-algebra on D [a, b] generated by the Skorohod topology
is the same as the σ-algebra on D [a, b] generated by the coordinate projections.
The first statement of this theorem can be found in Billingsley [3], Chapter 3, the second
statement is Theorem 14.5 in the same book.
The next lemma is an easy consequence of the existence of conditional distributions:
Lemma D.5. Let X and Y be random variables on a probability space (Ω,F , P ) with
values in (R,B), with B the Borel-σ-algebra on R. Suppose that G ⊂ F is a sub-σ-algebra.
Then there exist conditional distributions PX|G and PY |G. If moreover for every x ∈ Q,
P (X ≤ x|G) = P (Y ≤ x|G) a.s., then PX|G = PY |G a.s. in the sense that there exists a
P -null set N ∈ F such that for all ω ∈ Ω \N and all B ∈ B,
PX|G (ω,B) = PY |G (ω,B) .
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Proof. Existence of conditional distributions follows from Theorem D.3 since (R,B) is a
Polish space. Furthermore a probability measure on (R,B) is completely determined by
its values on (−∞, x] for x ∈ Q. So it is enough to prove that there exists a P -null set
N ∈ F such that
∀ω ∈ Ω \N ∀x ∈ Q PX|G (ω, (−∞, x]) = PY |G (ω, (−∞, x]) . (48)
But for every x ∈ Q,
PX|G (ω, (−∞, x]) = P (X ≤ x|G) a.s.
= P (Y ≤ x|G) a.s.
= PY |G (ω, (−∞, x]) a.s.
Define
N = ∪x∈Q
{
ω : PX|G (ω, (−∞, x]) 6= PY |G (ω, (−∞, x])
}
.
This is a countable union of null sets, so a null set, and it satisfies (48). ✷
For the proof of Lemma D.8 and Lemma D.9, the following two lemma’s are used. The
first is well-known.
Lemma D.6. If PX|G is a conditional distribution of X given G then
E [f (X) |G] =
∫
f (x) dPX|G (x) a.s..
Lemma D.7. Suppose that Z and Y are random variables on a probability space (Ω,F , P )
with values in Polish spaces (Y ,A1) and (Z,A2), respectively. Then
(ω,A) 7−→
∫
A
δz′,z(ω)PY |Z=z(ω) (dy) dz
′
: Ω×σ (A1 ×A2)→ R is a version of P(Y,Z)|Z , i.e. it is a conditional distribution function
of (Y, Z) given Z.
Proof. Define P˜ (ω,A) =
∫
A
δz′,z(ω)PY |Z=z(ω) (dy)dz
′. Condition a and b of Definition D.1
have to be checked for P˜ . Condition b: for ω fixed it is indeed a probability measure on
((Y ×Z) , σ (A1 ×A2)) (concentrated on z = z (ω)).
Condition a: first it is shown that for any A of the form A1 × A2 with A1 ∈ A1 and
A2 ∈ A2, ω → P˜ (ω,A1 × A2) is a version of P ((Y, Z) ∈ (A1 × A2) |Z). Equivalently, for
A of the form A1 ×A2 and G ∈ σ (Z), so G of the form Z−1 (B) with B ∈ A2,∫
G
P˜ (ω,A) dP (ω) =
∫
G
1A ((Y, Z)) dP = P
(
G ∩ (Y, Z)−1 (A)).
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This can be shown as follows:∫
Z−1(B)
P˜ (ω,A1 ×A2) dP (ω) =
∫
B
(∫
A1×A2
δz′,zPY |Z=z (dy
′) dz′
)
dPZ (z)
=
∫
B∩A2
(∫
A1
PY |Z=z (dy
′)
)
dPZ (z)
=
∫
B∩A2
P (Y ∈ A1|Z = z) dPZ (z)
= P
(
Y −1 (A1) ∩ Z−1 (B ∩ A2)
)
= P
(
Z−1 (B) ∩ (Y, Z)−1 (A1 ×A2)
)
.
Next it is shown that this is sufficient. Notice first that since ((Y × Z) , σ (A1 ×A2)) is
a Polish space, there exists a conditional distribution P(Y,Z)|Z . We show that P˜ and P(Y,Z)|Z
are almost surely equal, using the Uniqueness Theorem on page 27 of Bauer [2]. Remark
that both A1 and A2 are countably generated, say by A01 and A02, so that σ (A1 ×A2)
is countably generated by A01 × A02: every A1 × A2 is an element of σ
(A01 × A02), since
A1 × A2 = A1 × Z ∩ Y × A2. To apply the Uniqueness Theorem we need a generator
which is intersection-stable (i.e., finite intersections of elements in A01 × A02 are still in
A01 ×A02). A01 ×A02 need not be intersection-stable, but as in the proof of Theorem 10.3.4
in Bauer [2]: when finite intersections of elements in A01 × A02 are added to the generator
it stays countable. Notice that these finite intersections are still of the form A1 ×A2 since
(A1 ×A2) ∩ (B1 ×B2) = (A1 ∩ B1)× (A2 × B2), and notice moreover that this leads to a
countable intersection-stable generator A11 ×A12. Because of the former paragraph, for all
A1×A2 with A1 ∈ A1 and A2 ∈ A2, P˜ (ω,A11 × A12) is a version of P ((Y, Z) ∈ A11 × A12|Z),
so P˜ (ω,A11 × A12) = P(Y,Z)|Z (ω,A11 × A12) a.s. Hence because of the countability
∪A11×A12:A11∈A11,A12∈A12
{
ω : P˜
(
ω,A11 × A12
) 6= P(Y,Z)|Z (ω,A11 × A12)}
is a null set. Thus the Uniqueness Theorem on page 27 of Bauer [2] implies that indeed P˜
and P(Y,Z)|Z are equal except for on this null set. ✷
Lemma D.8. Suppose that Y has a continuous conditional distribution function FY |Z given
Z. Then FY |Z (Y ) is uniformly distributed on [0, 1] and independent of Z.
Proof. Because of Lemma D.5 it suffices to prove that for all x ∈ [0, 1],
P
(
FY |Z (Y ) ≤ x|Z
)
= x a.s. This can be done as follows. Define
F−1
Y |Z (x+) = sup
{
y : FY |Z(y) ≤ x
}
.
Then
P
(
FY |Z (Y ) ≤ x|Z = z
)
= P
(
Y ≤ F−1
Y |Z (x+) |Z = z
)
,
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since FY |Z(Y ) ≤ x implies that Y ≤ sup
{
y : FY |Z(y) ≤ x
}
= F−1
Y |Z (x+) and since Y ≤
F−1
Y |Z (x+) = sup
{
y : FY |Z(y) ≤ x
}
implies that FY |Z(Y ) ≤ x by continuity of FY |Z . Hence
P
(
FY |Z (Y ) ≤ x|Z = z
)
= E
[
1{
Y≤F−1
Y |Z
(x+)
} ∣∣Z = z]
=
∫
(y,z′):y≤F−1
Y |Z=z′
(x+)
P(Y,Z)|Z=z (dy, dz
′)
=
∫
(y,z′):y≤F−1
Y |Z=z′
(x+)
δz,z′FY |Z=z (dy)dz
′
=
∫
y:y≤F−1
Y |Z=z
(x+)
FY |Z=z (dy)
= FY |Z
(
F−1
Y |Z (x+)
)
= x a.s.,
where Lemma D.6 is used in the second line, Lemma D.7 in the third line, and continuity
of FY |Z in the last line. ✷
Lemma D.9. Suppose that X is uniformly distributed on [0, 1] and independent of Z
and that FY |Z is a conditional distribution function of Y given Z. Then F
−1
Y |Z (X) has
conditional distribution function FY |Z given Z.
Proof. Because of Lemma D.5 it suffices to prove that for all s,
P
(
F−1
Y |Z (X) ≤ s|Z
)
= FY |Z (s) a.s. This can be done as follows:
P
(
F−1
Y |Z (X) ≤ s|Z = z
)
= P
(
F−1
Y |Z(X) ≤ F−1Y |Z ◦ FY |Z(s)|Z = z
)
= P
(
X ≤ FY |Z (s) |Z = z
)
= E
[
1{X≤FY |Z(s)}
∣∣Z = z]
=
∫
(x′,z′):x′≤FY |Z=z′(s)
P(X,Z)|Z=z (dx
′, dz′)
=
∫
(x′,z′):x′≤FY |Z=z′(s)
δz,z′FX|Z=z (dx
′) dz′
=
∫
x′:x′≤FY |Z=z(s)
FX|Z=z (dx
′)
= FY |Z (s) a.s..
In the second line it is used that if X ≤ FY |Z(s) then also F−1Y |Z(X) ≤ F−1Y |Z ◦ FY |Z(s),
and moreover that if X > FY |Z(s) then also, since FY |Z(s) is in the range of FY |Z and
conditional distribution functions are right continuous, F−1
Y |Z(X) > F
−1
Y |Z ◦ FY |Z(s). In the
fourth line I use Lemma D.6, in the fifth line Lemma D.7 is used, and in the last line it is
used that X is uniformly distributed on [0, 1] given Z. ✷
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Lemma D.10. If X is a random variable taking values in R and for every bounded Lips-
chitz continuous function f : R→ R
E [f (X) |Z] = E [f (Y ) |Z] a.s.
then X has the same conditional distribution as Y given Z.
Proof. Because of Lemma D.5 it suffices to show that for every x ∈ R,
P (X ≤ x|Z) = P (Y ≤ x|Z) a.s.
Analogously to a proof of the Portmanteau Lemma, define
fm (y) = m d (y, (−∞, x]) ∧ 1
for m = 1, 2, . . .. Then 0 ≤ fm ↑ 1(x,∞) as m → ∞ and fm is bounded and Lipschitz, so
that E [fm (X) |Z] = E [fm (Y ) |Z] a.s. The remaining part is straightforward:
P (X ≤ x|Z) = E [1(−∞,x] (X) |Z]
= E
[
1− 1(x,∞) (X) |Z
]
= 1− E [1(x,∞) (X) |Z] a.s.
= 1− lim
m→∞
E [fm (X) |Z] a.s.
= 1− lim
m→∞
E [fm (Y ) |Z] a.s.
= P (Y ≤ x|Z) a.s.,
where in the fourth line the conditional Monotone Convergence Theorem (see e.g. [5]) is
used. ✷
Proof of Lemma A.2. Remark that σ
(
Z
(n)
t
)
is increasing in n, and that for t on the
infinite grid σ
(∪∞n=1Z(n)t ) = σ (Zt) and for t not on the infinite grid σ(∪∞n=1Z(n)t ) = σ (Zt−),
where Zt− = (Z(s) : s < t). But the probability that Z jumps at time t is equal to
zero. Therefore E
[
X|Zt
]
= E
[
X|Zt−
]
a.s.: any version of E
[
X|Zt−
]
is a version of
E
[
X|Zt
]
. This can be seen as follows. E
[
X|Zt−
]
is trivially σ
(
Zt
)
-measurable. So it
still has to be checked that for any measurable f : Z t → R for which E
(∣∣Xf (Zt)∣∣) <∞,
E
(
Xf
(
Zt
))
= E
(
E
[
X|Zt−
]
f
(
Zt
))
. So let f with E
(∣∣Xf (Zt)∣∣) <∞ be given. Define
g : Z t− → Z t as the “continuous” extension:
g (zt−) (s) =
{
z(s) if s < t
limu↑t z(u) if s = t.
Then
E
(
Xf
(
Zt
))
= E
(
Xf
(
g
(
Zt−
)))
= E
(
E
[
X|Zt−
]
f
(
g
(
Zt−
)))
= E
(
E
[
X|Zt−
]
f
(
Zt
))
,
where in the first and the last line it is used that the probability that Z jumps at time t is
equal to zero. Therefore the conditional expectation of X given Zt is almost surely equal
to the conditional expectation of X given σ
(∪∞n=1Z(n)t ). ✷
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E Web-Appendix: A corollary of the Local Inverse
Function Theorem
Continuation of the proof of Lemma 7.7. It is easy to see that φ is differentiable
at (0, y0) with non-singular derivative. Therefore, the Local Inverse Function Theorem
implies that there exists an open neighbourhood Vh0,y0 of (h0, y0) such that W = φ (Vh0,y0)
is open and φ|Vh0,y0 : Vh0,y0 →W is a C
1-diffeomorphism. Hence φ−1 exists and is C1.
Notice that φ−1 (h, x) must have the form (h, y) with y satisfying Fh (y) = x. For
(h, x) ∈ W such y is unique, since all Fh are non-decreasing by assumption and F ′h (y) is
non-zero on Vh0,y0. Thus F
−1
h (x) is well-defined on W , and it follows that
φ−1 (h, x) =
(
h, F−1h (x)
)
.
Both φ and φ−1 are C1, so the chain rule can be applied to calculate(
1 0
0 1
)
= D
(
φφ−1
)
(h, x)
= (Dφ)
(
φ−1 (h, x)
) · (Dφ−1) (h, x)
=
(
1 0
∂
∂h
Fh (y) F
′
h (y)
)
·
(
1 0
∂
∂h
F−1h (x)
(
F−1h
)′
(x)
)
,
with y = F−1h (x). Lemma 7.7 follows by comparing the bottom left entries of the matrices
on the left- and right hand side of this equation. ✷
F Web-Appendix: Lipschitz continuity and differen-
tiability
The following lemma can be useful for proving Lipschitz continuity of quotients of functions.
Lemma F.1. Suppose that f and g are functions from R to R which are Lipschitz contin-
uous with Lipschitz constants Lf resp. Lg. Suppose furthermore that g ≥ ε for some ε > 0
and |f | ≤ C for some C > 0. Then f/g is Lipschitz continuous with Lipschitz constant
e.g. Lf/ε+ C Lg/ε
2.
Proof.∣∣∣∣f (x1)g (x1) −
f (x2)
g (x2)
∣∣∣∣ ≤
∣∣∣∣f (x1)g (x1) −
f (x2)
g (x1)
∣∣∣∣+
∣∣∣∣f (x2)g (x1) −
f (x2)
g (x2)
∣∣∣∣
=
∣∣∣∣ 1g (x1)
∣∣∣∣ |f (x1)− f (x2)|+
∣∣∣∣ f (x2)g (x1) g (x2)
∣∣∣∣ |g (x1)− g (x2)|
≤ 1
ε
Lf |x1 − x2|+ C
ε2
Lg |x1 − x2| . ✷
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The next lemma deals with a continuous function f on a closed interval which is con-
tinuously differentiable on the interior of that interval. If f ′ can be continuously extended
to the closed interval, then f is continuously differentiable on the closed interval.
Lemma F.2. Suppose that f is continuous on [t1, t2] and f is continuously differentiable
on (t1, t2). Suppose furthermore that f
′ has a continuous extension to [t1, t2]. Then f is
differentiable from the right at t1 with derivative limt↓t1 f
′ (t) and differentiable from the
left at t2 with derivative limt↑t2 f
′ (t).
Proof. I just prove the statements for t1; the proof for t2 is similar. Define g (t) =
f (t1) +
∫ t
t1
f ′ (x) dx. Then g is continuous and continuously differentiable on [t1, t2) with
derivative f ′(t) on (t1, t2) and limt↓t1 f
′ (t1) at t1. It suffices to show that f = g on [t1, t2),
since then f has the same properties as g on [t1, t2). To do this, remark first that f − g
is constant on (t1, t2) since it is differentiable there with derivative 0. Because f − g is
continuous on [t1, t2), f − g is also constant on [t1, t2). (f − g) (t1) = 0. Thus f = g on
[t1, t2). ✷
G Web-Appendix: Some theory about differential equa-
tions
Theorem G.1. Suppose that a function D
(
y, t;Zt
)
satisfies
a) (continuity between the jump times of Z). If Z does not jump in (t1, t2) then D
(
y, t;Zt
)
is continuous in (y, t) on [t1, t2) and can be continuously extended to [t1, t2].
b) (Lipschitz continuity). For each ω ∈ Ω there exists a constant L (ω) such that∣∣D (y, t;Zt)−D (z, t;Z t)∣∣ ≤ L (ω) |y − z|
for all t ∈ [0, τ ] and all y, z.
Suppose furthermore that for each ω ∈ Ω there are no more than finitely many jump times
of Z. Then, for each t0 ∈ [0, τ ] and y0 ∈ R, there is a unique continuous solution x (t; t0, y0)
to
dx(t)/dt = D
(
x(t), t;Zt
)
with boundary condition x (t0) = y0 and this solution is defined for all t ∈ [0, τ ].
This theorem follows from well-known results about differential equations, see e.g. Duis-
termaat and Eckhaus [4] Chapter 2.
For the next theorem we also refer to Duistermaat and Eckhaus [4] Chapter 2. It is a
consequence of Gronwall’s lemma.
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Theorem G.2. Suppose that I is an open or closed interval in R, f : I × Rn → Rn is
continuous and C : I → [0,∞) is continuous, and suppose that
‖ f (x, y)− f (x, z) ‖≤ C (x) ‖ y − z ‖ (49)
for all x ∈ I and y, z ∈ Rn. Then, for every x0 ∈ I and y0 ∈ R, there is a unique solution
y (x) of y′ (x) = f (x, y(x)) with y (x0) = y0, and this solution is defined for all x ∈ I. If
g : I × Rn → Rn is continuous and z : I → Rn is a solution of z′ (x) = g (x, z(x)) then
‖ y (x)− z (x) ‖
≤ e
∫ x
x0
C(ξ)dξ ‖ y (x0)− z (x0) ‖ +
∫ x
x0
e
∫ x
ξ
C(η)dη ‖ f (ξ, z (ξ))− g (ξ, z (ξ)) ‖ dξ
for all x, x0 ∈ I with x0 ≤ x.
In Duistermaat and Eckhaus [4] the interval is always an open interval, but as is gen-
erally known this can be overcome by extending both f and g outside the closed interval
I by taking the values at the boundary of I. This preserves the Lipschitz- and continu-
ity conditions. Existence and uniqueness on all of finitely many intervals implies global
existence and uniqueness; this is the way one often applies this theorem.
This article is about a differential equation with end condition at τ , so interested lies
in x, x0 with x ≤ x0. The following corollary can be used.
Corollary G.3. Suppose that the conditions of Theorem G.2 are satisfied. Then, for every
x0 ∈ I and y0 ∈ Rn, there is a unique solution y (x) of y′ (x) = f (x, y(x)) with y (x0) = y0,
and this solution is defined for all x ∈ I. If g : I ×Rn → Rn is continuous and z : I → Rn
is a solution of z′ (x) = g (x, z(x)) then
‖ y (x)− z (x) ‖
≤ e
∫ x0
x
C(s)ds ‖ y (x0)− z (x0) ‖ +
∫ x0
x
e
∫ s
x
C(η)dη ‖ f (s, z (s))− g (s, z (s)) ‖ ds
for all x, x0 with x ≤ x0.
Proof. Define y˜ (t) = y (x0 − t). Then
y˜′ (t) =
∂
∂t
y (x0 − t)
= −y′ (x0 − t)
= −f (x0 − t, y (x0 − t))
= −f (x0 − t, y˜ (t))
= f˜ (t, y˜ (t))
where f˜ (t, y) = −f (x0 − t, y). So y˜ (t) = y (x0 − t) is a solution of the differential equation
y˜′ (t) = f˜ (t, y (t)) with boundary condition y˜ (0) = y (x0) = y0. Applying Theorem G.2 on
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y˜ concludes the proof, as follows.
‖ y(x)− z(x) ‖ = ‖ y(x− x0 + x0)− z(x− x0 + x0) ‖
= ‖ y(x0 − (x0 − x))− z(x0 − (x0 − x)) ‖
= ‖ y˜(x0 − x)− z˜(x0 − x) ‖
= ‖ y˜(t)− z˜(t) ‖
with t = x0 − x ≥ 0. Notice that since because of equation (49),
‖ f˜ (t, y)− f˜ (t, z) ‖≤ C (x0 − t) ‖ y − z ‖=: C˜(t) ‖ y − z ‖,
with C˜(t) = C(x0 − t). Hence Theorem G.2 implies that
‖ y(x)− z(x) ‖ ≤ e
∫ t
0
C˜(ξ)dξ ‖ y˜(0)− z˜(0) ‖ +
∫ t
0
e
∫ t
0
C˜(η)dη ‖ f˜ (ξ, z˜ (ξ))− g˜ (ξ, z˜(ξ)) ‖ dξ
= e
∫ t
0
C(x0−ξ)dξ ‖ y(x0 − 0)− z(x0 − 0) ‖
+
∫ t
0
e
∫ t
0
C(x0−η)dη ‖ f˜ (ξ, z˜ (ξ))− g˜ (ξ, z˜(ξ)) ‖ dξ.
For the first term a change of variables is done; ξ from 0 to t, define s = x0− ξ; dξ = −ds.
0 ≤ ξ ≤ t; s from x0− 0 to x0− t = x0− (x0−x) = x. Therefore, the first term is equal to
e
−
∫ x
x0
C(s)ds ‖ y(x0)− z(x0) ‖= e
∫ x0
x
C(s)ds ‖ y(x0)− z(x0) ‖ .
For the second term similar changes of variables can be done, resulting in Corollary G.3. ✷
Proof of Theorem A.1. Write I = [x1, x2]. In order to apply Theorem G.2 define an
extension f˜ : R× R→ R of f as follows:
f˜ (x, y) =


f (x, y) if (x, y) ∈ I × [y1, y2]
f (x1, y) if (x, y) ∈ (−∞, x1]× [y1, y2]
f (x2, y) if (x, y) ∈ (x2,∞)× [y1, y2]
f˜ (x, y1) if y < y1
f˜ (x, y2) if y > y2.
If there exists a unique solution of the differential equation with f˜ and this solution stays in
[y1, y2], then this solution is also the unique continuous solution of the differential equation
with f .
On the differential equation with f˜ , Theorem G.2 will be applied. f˜ is continuous on
R× R because f is continuous on I × [y1, y2] and f (x, y1) = 0 = f (x, y2) for every x ∈ I.
Also there exists a continuous C˜ satisfying equation (49): define C˜ as an extension of C
as follows:
C˜ (x) =


C (x) if x ∈ I
C (x1) if x ∈ (−∞, x1)
C (x2) if x ∈ (x2,∞) .
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That this C˜ satisfies equation (49) can easily be checked by first considering x ∈ [x1, x2]
and reducing different x to x1 and x2.
Thus Theorem G.2 implies that there is a unique solution of the differential equation
with f˜ . That the solution stays in [y1, y2] is clear from the fact that f˜ = 0 for y ∈ {y1, y2}
and the fact that the solution is unique.
Since g can be extended the same way as f and z stays in [y1, y2] by assumption, the
bound for |y (x)− z (x)| given by Theorem G.2 also holds here. The bound of Theorem A.1
follows with the same reasoning from Corollary G.3. This finishes the proof. ✷
Corollary G.4. Suppose that I = [x1, x2] ⊂ [0, y2] is a closed interval in R, f : {(x, y) ∈ I × [0, y2] : y ≥ x} →
R is continuous with for all x ∈ I, f (x, y2) = 0 and f (x, x) ≤ 1 and C : I → [0,∞) is
continuous, and suppose that
|f (x, y)− f (x, z)| ≤ C (x) |y − z|
for all x ∈ I and y, z ∈ [x, y2]. Then for every y0 ∈ [x2, y2] there is a unique solution y (x) of
y′ (x) = f (x, y(x)) with final condition y (x2) = y0, and this solution is defined for all x ∈ I.
Furthermore y (x) ∈ [x, y2] for all x ∈ I. Suppose that g : {(x, y) ∈ I × [0, y2] : y ≥ x} → R
is continuous and z : I → [0, y2] is a solution of z′ (x) = g (x, z(x)) with z (x) ≥ x then
|y (x)− z (x)|
≤ e
∫ x2
x
C(s)ds |y (x2)− z (x2)|+
∫ x2
x
e
∫ s
x
C(η)dη |f (s, z (s))− g (s, z (s))| ds
for all x ∈ I.
Proof. This can be proved the same way as Corollary A.1, if one defines
f˜ (x, y) =


f (x, y) if (x, y) ∈ I × [0, y2] : y ≥ x
f (x, y2) if x ∈ I and y > y2
f (x, x) if x ∈ I and y < x
f˜ (x1, y) if x < x1
f˜ (x2, y) if x > x2.
Remark that the solution y (x) stays in (x, y) ∈ I×[0, y2] : y ≥ x for x ∈ I since f (x, x) ≤ 1
and f (x, y2) = 0. ✷
Remark that if it is not known whether f (x, x) ≤ 1 but it is known that f is continuous in
(x, y) and Lipschitz continuous in y on the set mentioned in Corollary G.4, then the proof
above shows that if a solution y (x) exists for which y (x) ≥ x for x ≤ x2 then this solution
is unique.
H Web-Appendix: Convergence Theorems
A lemma with a corollary:
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Lemma H.1. Suppose that the random functions fω : [y1, y2] → R and fωn : [y1, y2] → R
(n = 1, 2, . . .) are ‘asymptotically uniformly equicontinuous with probability one’, i.e. there
exists Ω′ ⊂ Ω with P (Ω′) = 1 such that for all ω ∈ Ω′: ∀ε > 0 ∃δ > 0 ∃N : ∀n ≥ N :
|y − z| < δ ⇒
{ |fωn (y)− fωn (z)| < ε
|fω (y)− fω (z)| < ε.
Suppose furthermore that for all y ∈ (y1, y2) ∩Q, fωn (y)→ fω (y) a.s. Then
sup
y∈[y1,y2]
|fωn (y)− fω (y)| → 0 a.s.
Remark: the regularity condition for Lemma H.1 is e.g. satisfied if there is a Lipschitz
constant L such that all fω and fωn are Lipschitz continuous in y with Lipschitz constant
L (define δ = ε/L).
Proof. Define Ω′′ = {ω : fωn (y)→ fω (y) ∀y ∈ Q ∩ (y1, y2)}. Then Ω′′ has probability one
(Ω minus countably many null sets). Define Ω0 = Ω
′ ∩ Ω′′. Then also Ω0 has probability
one. We show that for all ω ∈ Ω0: supy∈[y1,y2] |fωn (y)− fω (y)| → 0.
Let ω ∈ Ω0 and ε > 0 be given. To show: there exists an N such that ∀n ≥ N :
supy∈[y1,y2] |fωn (y)− fω (y)| < ε. Choose N1 and δ > 0 such that for all n ≥ N1:
|y − z| < δ ⇒
{ |fωn (y)− fωn (z)| < ε/3
|fω (y)− fω (z)| < ε/3.
This is possible because ω ∈ Ω′. Next choose y(1), . . . , y(N2) ∈ Q ∩ (y1, y2) such that for all
y ∈ [y1, y2] there is a y(i) with |y− y(i)| < δ. After this choose N3 such that for all n ≥ N3:
max
1≤i≤N2
∣∣fωn (y(i))− fω(y(i))∣∣ < ε/3.
This is possible because ω ∈ Ω′′ and the number of y(i)’s is finite. Then for n ≥ N =
max{N3, N1}:
|fωn (y)− fω (y)| ≤ min
1≤i≤N2
(∣∣fωn (y)− fωn (y(i))∣∣+ ∣∣fω(y(i))− fω (y)∣∣)
+ max
1≤i≤N2
(∣∣fωn (y(i))− fω(y(i))∣∣)
< ε/3 + ε/3 + ε/3 = ε. ✷
Corollary H.2. Under the conditions of Lemma H.1, if Xn is a series of random variables
with values in [y1, y2], then
|fωn (Xn)− fω (Xn)| → 0 a.s.
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